US20030229155A1 - Sequentially cross-linked polyethylene - Google Patents

Sequentially cross-linked polyethylene Download PDF

Info

Publication number
US20030229155A1
US20030229155A1 US10/454,815 US45481503A US2003229155A1 US 20030229155 A1 US20030229155 A1 US 20030229155A1 US 45481503 A US45481503 A US 45481503A US 2003229155 A1 US2003229155 A1 US 2003229155A1
Authority
US
United States
Prior art keywords
irradiation
set forth
polyethylene
annealing
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/454,815
Inventor
Aiguo Wang
John Dumbleton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Howmedica Osteonics Corp
Original Assignee
Howmedica Osteonics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howmedica Osteonics Corp filed Critical Howmedica Osteonics Corp
Priority to US10/454,815 priority Critical patent/US20030229155A1/en
Assigned to HOWMEDICA OSTEONICS CORP. reassignment HOWMEDICA OSTEONICS CORP. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DUMBLETON, JOHN H., WANG, AIGUO
Publication of US20030229155A1 publication Critical patent/US20030229155A1/en
Priority to US10/957,782 priority patent/US7517919B2/en
Priority to US12/315,994 priority patent/US7714036B2/en
Priority to US12/757,394 priority patent/US8030370B2/en
Priority to US13/223,422 priority patent/US8324291B2/en
Priority to US13/658,037 priority patent/US8680173B2/en
Priority to US14/174,035 priority patent/US9181409B2/en
Priority to US14/876,344 priority patent/US9650476B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/28Treatment by wave energy or particle radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/247Heating methods
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/04Homopolymers or copolymers of ethene
    • C08L23/06Polyethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2312/00Crosslinking
    • C08L2312/06Crosslinking by radiation

Definitions

  • This invention relates to medical implants formed of a polymeric material such as ultra-high molecular weight polyethylene, with superior oxidation and wear resistance produced by a sequential irradiation and annealing process.
  • Ultra-high molecular weight polyethylene is widely used for articulation surfaces in artificial knee, hip, and other joint replacements.
  • Ultra-high molecular weight polyethylene has been defined as those linear polyethylenes which have a relative viscosity of 2.3 or greater at a solution concentration of 0.05% at 135° C. in decahydronaphthalene.
  • the nominal weight—average molecular weight is at least 400,000 and up to 10,000,000 and usually from three to six million.
  • the manufacturing process begins with the polymer being supplied as fine powder which is consolidated into various forms, such as rods and slabs, using ram extrusion or compression molding. Afterwards, the consolidated rods or slabs are machined into the final shape of the orthopedic implant components. Alternatively, the component can be produced by compression molding of the UHMWPE resin powder.
  • reaction 7 it has been found that the hydroperoxides (rOOH and POOH) formed in reactions 3 and 5 will slowly break down as shown in reaction 7 to initiate post-radiation degradation.
  • Reactions 8 and 9 represent termination steps of free radicals to form ester or carbon-carbon cross-links.
  • the extent of reactions 8 and 9 in relation to reactions 2 through 7 may vary.
  • irradiated UHMWPE a value of 0.3 for the ratio of chain scission to cross-linking has been obtained, indicating that even though cross-linking is a dominant mechanism, a significant amount of chain scission occurs in irradiated polyethylene.
  • the primary free radicals r. or secondary free radicals P. can only react with other neighboring free radicals to form carbon-carbon cross-links, according to reactions 10 through 12 below. If all the free radicals react through reactions 10 through 12, there will be no chain scission and there will be no molecular weight degradation. Furthermore, the extent of cross-linking is increased over the original polymer prior to irradiation. On the other hand, if not all the free radicals formed are combined through reactions 10, 11 and 12, then some free radicals will remain in the plastic component.
  • UHMWPE is commonly used to make prosthetic joints such as artificial hip joints.
  • tissue necrosis and interface osteolysis may occur in response to UHMWPE wear debris.
  • wear of acetabular cups of UHMWPE in artificial hip joints may introduce microscopic wear particles into the surrounding tissues.
  • UHMWPE ultrahigh molecular weight polyethylene
  • high energy radiation for example gamma radiation
  • Exposure of UHMWPE to gamma irradiation induces a number of free-radical reactions in the polymer.
  • One of these is cross-linking.
  • This cross-linking creates a 3-dimensional network in the polymer which renders it more resistant to adhesive wear in multiple directions.
  • the free radicals formed upon irradiation of UHMWPE can also participate in oxidation which reduces the molecular weight of the polymer via chain scission, leading to degradation of physical properties, embrittlement and a significant increase in wear rate.
  • the free radicals are very long-lived (greater than eight years), so that oxidation continues over a very long period of time resulting in an increase in the wear rate as a result of oxidation over the life of the implant.
  • Hyun et al. U.S. Pat. No. 6,168,626 relates to a process for forming oriented UHMWPE materials for use in artificial joints by irradiating with low doses of high-energy radiation in an inert gas or vacuum to cross-link the material to a low degree, heating the irradiated material to a temperature at which compressive deformation is possible, preferably to a temperature near the melting point or higher, and performing compressive deformation followed by cooling and solidifying the material.
  • the oriented UHMWPE materials have improved wear resistance. Medical implants may be machined from the oriented materials or molded directly during the compressive deformation step. The anisotropic nature of the oriented materials may render them susceptible to deformation after machining into implants.
  • Salovey et al. U.S. Pat. No. 6,228,900 relates to a method for enhancing the wear-resistance of polymers, including UHMWPE, by cross-linking them via irradiation in the melt.
  • Saum et al. U.S. Pat. No. 6,316,158 relates to a process for treating UHMWPE using irradiation followed by thermally treating the polyethylene at a temperature greater than 150° C. to recombine cross-links and eliminate free radicals.
  • UHMWPE powders being heated and compressed into a homogeneously melted crystallized morphology with no grain memory of the UHMWPE powder particles and with enhanced modulus and strength.
  • U.S. Pat. No. 5,037,928 relates to a prescribed heating and cooling process for preparing a UHMWPE exhibiting a combination of properties including a creep resistance of less than 1% (under exposure to a temperature of 23° C. and a relative humidity of 50% for 24 hours under a compression of 1000 psi) without sacrificing tensile and flexural properties.
  • Patent Application GB 2 180 815 A relates to a packaging method where a medical device which is sealed in a sterile bag, after radiation/sterilization, is hermetically sealed in a wrapping member of oxygen-impermeable material together with a deoxidizing agent for prevention of post-irradiation oxidation.
  • U.S. Pat. No. 5,153,039 relates to a high density polyethylene article with oxygen barrier properties.
  • U.S. Pat. No. 5,160,464 relates to a vacuum polymer irradiation process.
  • the present invention relates to a method for providing a polymeric material, such as UHMWPE, with superior oxidation resistance, mechanical strength and wear properties.
  • UHMWPE will be used as an example to describe the invention.
  • all the theories and processes described hereafter should also apply to other polymeric materials such as polypropylene, high density polyethylene, polyhydrocarbons, polyester, nylon, polyurethane, polycarbonates and poly(methylmethcrylate) unless otherwise stated.
  • the method involves using a series of relatively low doses of radiation with an annealing process after each dose.
  • UHMWPE polymer is very stable and has very good resistance to aggressive media except for strong oxidizing acids.
  • free radicals are formed which cause UHMWPE to become activated for chemical reactions and physical changes.
  • Possible chemical reactions include reacting with oxygen, water, body fluids, and other chemical compounds while physical changes include density, crystallinity, color, and other physical properties.
  • the sequential radiation and annealing process greatly improves the physical properties of UHMWPE when compared to applying the same total radiation dose in one step. Furthermore, this process does not employ stabilizers, antioxidants, or any other chemical compounds which may have potentially adverse effects in biomedical or orthopedic applications.
  • An orthopedic preformed material such as a rod, bar or compression molded sheet for the subsequent production of a medical implant such as an acetabular or tibial implant with improved wear resistance is made from a polyethylene material cross-linked at least twice by irradiation and thermally treated by annealing after each irradiation.
  • the material is cross-linked by a total radiation dose of from about 2 MRads to 100 MRads and preferably between 5 MRads and 10 MRads.
  • the incremental dose for each irradiation is between about 2 MRads and about 5 MRads.
  • the weight average molecular weight of the material is over 400,000.
  • the annealing takes place at a temperature greater than 25° C., preferably between 110° C. and 135° C. but less than the melting point. Generally, the annealing takes place for a time and temperature selected to be at least equivalent to heating the irradiated material at 50° C. for 144 hours as defined by Arrenhius' equation 14. The material is heated for at least about 4 hours and then cooled to room temperature for the subsequent irradiation in the series.
  • the crystallinity will fluctuate between 55% and 60% (instead of 55-65%) and hence both the amount of chain-scission and residual free-radical concentration can be significantly reduced.
  • the polyethylene of the present invention may be in the form of a preformed rod or sheet with a subsequent production of a medical implant with improved wear resistance.
  • the preformed rod or sheet is cross-linked at least twice by irradiation and thermally treated by annealing after each radiation.
  • the incremental dose for each radiation is preferably between about 2 and 5 MRads with the total dose between 2 and 100 MRads and preferably between 5 and 10 MRads.
  • the preformed material is annealed either in air or in an inner atmosphere at a temperature of greater than 25° C. and preferably less than 135° C. or the melting point.
  • the annealing takes place for a time and temperature selected to be at least equivalent to heating the irradiated material at 50° C. for 144 hours as defined by Arrenhius' equation (14).
  • each heat treatment lasts for at least 4 hours and preferably about 8 hours.
  • the preformed polyethylene material is then machined into a medical implant or other device. If the irradiation process occurred in air, then the entire outer skin to about 2 mm deep is removed from the preform prior to machining the medical implant or other device. If the process was done in a vacuum or an inner atmosphere such a nitrogen, then the outer skin may be retained.
  • the end-results of reduced chain-scission and free-radical concentration are improved mechanical properties, improved oxidation resistance and enhanced wear resistance.
  • FIG. 1 shows the oxidation index profiles of the specimens of Example 8.
  • FIG. 2 shows the oxidation index profiles of the specimens of Example 11.
  • UHMWPE ultra-high molecular weight polyethylene
  • HMWPE high molecular weight polyethylene
  • This invention provides a method for improving the wear resistance of a polymer by crosslinking (preferably the bearing surface of the polymer) and then thermally treating the polymer, and the resulting polymer. Preferably, the most oxidized surface of the polymer is also removed. Also presented are the methods for using the polymeric compositions for making products and the resulting products, e.g., in vivo implants.
  • the method of the invention utilizes at least two separate irradiations for crosslinking a polymer followed by a like number of thermal treatments to decrease the free radicals to produce either a treated fully formed or a preformed polymeric composition.
  • preformed polymeric composition means that the polymeric composition is not in a final desired shape or from (i.e., not a final product).
  • the at least two irradiations and thermal treatments of the polymer could be performed at pre-acetabular cup shape, such as when the preformed polymeric composition is in the form of a solid bar or block.
  • the process of the present invention could be applied to a fully formed implant if the process is done with the implant in an oxygen reduced atmosphere.
  • the wear resistance of a polymer is improved by crosslinking.
  • the crosslinking can be achieved by various methods known in the art, for example, by irradiation from a gamma radiation source or from an electron beam, or by photocrosslinking.
  • the preferred method for crosslinking the polymer is by gamma irradiation.
  • the polymer is preferably crosslinked in the form of an extruded bar or molded block.
  • the crosslinked polymer is subjected to thermal treatment such as by annealing (i.e. heated above at or below the melting temperature of the crosslinked polymer) to produce the preformed polymeric composition.
  • thermal treatment such as by annealing (i.e. heated above at or below the melting temperature of the crosslinked polymer) to produce the preformed polymeric composition.
  • the outer layer of the resulting preformed polymeric composition which is generally the most oxidized and least crosslinked and, thus, least wear resistant, is removed.
  • the bearing surface of the preformed polymeric composition may be fashioned from inside, e.g., by machining away the surface of the irradiated and thermally treated composition before or during fashioning into the final product, e.g., into an implant. Bearing surfaces are surfaces which are in moving contact, e.g., in a sliding, pivoting, or rotating relationship to one another.
  • High molecular weight (HMW) and ultra-high molecular weight (UHMW) polymers are preferred, such as HMW polyethylene (HMWPE), UHMW polyethylene (UHMWPE), and UHMW polypropylene.
  • HMW polymers have molecular weights ranging from about 10 5 grams per mole to just below 10 6 .
  • UHMW polymers have molecular weights equal to or higher than 10 6 grams per mole, preferably from 10 6 to about 10 7 .
  • the polymers are generally between about 400,000 grams per mole to about 10,000,000 and are preferably polyolefinic materials.
  • the preferred polymers are those that are wear resistant and have exceptional chemical resistance.
  • UHMWPE is the most preferred polymer as it is known for these properties and is currently widely used to make acetabular cups for total hip prostheses and components of other joint replacements.
  • UHMWPE examples of UHMWPE are those having molecular weight ranging from about 1 to 8 ⁇ 10 6 grams per mole, examples of which are: GUR 1150 or 1050 (Hoechst-Celanese Corporation, League City, Tex.) with a weight average molecular weight of 5 to 6 ⁇ 10 6 grams per mole; GUR 1130 with a weight average molecular weight of 3 to 4 ⁇ 10 6 ; GUR 1120 or 1020 with a weight average molecular weight of 3 to 4 ⁇ 10 6 ; RCH 1000 (Hoechst-Celanese Corp.) with a weight average of molecular weight of 4 ⁇ 10 6 and HiFax 1900 of 2 to 4 ⁇ 10 6 (HiMont, Elkton, Md.). Historically, companies which make implants have used polyethylenes such as HIFAX 1900, GUR 1020, GUR 1050, GUR 1120 and GUR 1150 for making acetabular cups.
  • GUR 1150 or 1050 Hoechst-Ce
  • Sterilization Methods All polymeric products must be sterilized by a suitable method prior to implanting in the human body.
  • a suitable method for the formed crosslinked and thermally treated polymeric compositions (i.e., the final products) of the present invention, it is preferable that the products be sterilized by a non-radiation based method, such as ethylene oxide or gas plasma, in order not to induce additional crosslinking free radicals and/or oxidation of the previously treated preformed polymeric composition.
  • a non-radiation sterilization method has a minor effect on the other important physical characteristics of the product.
  • the degree of crystallinity can be determined using methods known in the art, e.g. by differential scanning calorimetry (DSC), which is generally used to assess the crystallinity and melting behavior of a polymer.
  • DSC differential scanning calorimetry
  • Wide-angle X-ray scattering from the resulting polymer can also be used to further confirm the degree of crystallinity of the polymer, e.g. as described in Spruiell, J. E., & Clark, E. S., in “ Methods of Experimental - Physics,” L. Marton & C. Marton, Eds., Vol. 16, Part B, Academic Press, New York (1980).
  • Other methods for determining the degree of crystallinity of the resulting polymer may include Fourier Transform Infrared Spectroscopy (FTIR), e.g., as described in “Fourier Transform Infrared Spectroscopy And Its Application To Polymeric Materials,” John Wiley and Sons, New York, U.S.A.
  • FTIR Fourier Transform Infrared Spectroscopy
  • Another aspect of the invention presents a process for making implants using the preformed polymeric composition of the present invention.
  • the preformed polymeric composition may be shaped, e.g., machined, into the appropriate implants using methods known in the art.
  • the shaping process such as machining, removing the oxidized surface of the composition.
  • the preformed polymeric compositions of the present invention can be used in any situation where a polymer, especially UHMWPE, is called for, but especially in situations where high wear resistance is desired. More particularly, these preformed polymeric compositions are useful for making implants.
  • an important aspect of this invention presents implants that are made with the above preformed polymeric compositions or according to the methods presented herein.
  • the implants are produced from preformed polymeric composition made of UHMWPE irradiated and crosslinked at least twice each time followed by annealing and then removing the oxidized surface layer and then fabricating into a final shape.
  • the preformed polymeric composition of the present invention can be used to make the acetabular cup, or the insert or liner of the cup, or trunnion bearings (e.g. between the modular head and the hip stem).
  • the tibial plateau (femoro-tibial articulation), the patellar button (patello-femoral articulation), and/or other bearing components, depending on the design of the artificial knee joint.
  • the process can be used in the glenoid component.
  • the preformed polymeric composition can be used to make the talar surface (tibiotalar articulation) and other bearing components.
  • the preformed polymeric composition can be used to make the radio-humeral joint, ulno-humeral joint, and other bearing components.
  • the preformed polymeric composition can be used to make intervertebral disk replacement and facet joint replacement.
  • the preformed polymeric composition can also be made into temporo-mandibular joint (jaw) and finger joints.
  • jaw temporo-mandibular joint
  • finger joints The above are by way of example, and are not meant to be limiting.
  • the first aspect of the invention provides preformed polymeric compositions which are wear resistant and useful for making in vivo implants.
  • the at least two (2) incremental irradiation doses are preferably from about 1 to about 100 Mrad, and more preferably, from about 2 to about 5 Mrad. This most preferable range is based on achieving a reasonable balance between improved wear resistance and minimal degradation of other important physical properties.
  • the total dose is between 2 and 100 MRad and more preferably 5 to about 10 MRads.
  • a higher dose than the above stipulated most preferable range e.g., 5 to 10 Mrad
  • the optimum radiation dose is preferably based on the total dose received at the level of the bearing surface in the final product. Gamma radiation is preferred.
  • the preferred annealing temperature after each sequential irradiation is below the melting temperature of the UHMWPE which is generally below 135° C.
  • the annealing temperature is preferably from about room temperature to below the melting temperature of the irradiated polymer; more preferably from about 90° C. to about 1° C. below the melting temperature of the irradiated polymer; and most preferably from about 110° C. to about 130° C.
  • UHMWPE may be annealed at a temperature from about 25° C. to about 140° C., preferably from about 50° C. to about 135° C. and more preferably from about 80° C. to about 135° C. and most preferably between 110° C. to 130° C.
  • the annealing period is preferably from about 2 hours to about 7 days, and more preferably from about 7 hours to about 5 days and most preferably from about 10 hours to about 24 hours.
  • the appropriate amount of crosslinking may be determined based on the degree of swelling, gel content, or molecular weight between crosslinks after thermal treatment.
  • This alternative is based on the applicant's findings (detailed below) that acetabular cups made from UHMWPE falling within a preferred range of these physical parameters have reduced or non-detectable wear.
  • the ranges of these physical parameters include one or more of the following: a degree of swelling of between about 1.7 to about 5.3; molecular weight between crosslinks of between about 400 to about 8400 g/mol; and a gel content of between about 95% to about 99%.
  • a preferred polymer or final product has one or more, and preferably all, of the above characteristics.
  • the most oxidized surface of the preformed polymeric composition is removed.
  • the depth profiles of oxidation of the preformed polymeric composition can be determined by methods known in the art, such as FTIR.
  • the most oxidized surface of preformed polymeric composition which is exposed to air is removed, e.g. by machining, before or while fashioning the preformed polymeric composition into the final product. Since oxygen diffuses through the polyethylene with time, the sequential irradiation/annealing preferably should be completed prior to oxygen diffusing in high concentrations to the area of the preform from which the final part is made.
  • the most preferable range of total dose for crosslinking radiation was based on Wang et al. “Tribology International” Vol. 3, No. 123 (1998) pp. 17-35.
  • the gap in time before annealing is preferably seven days but at least before any oxygen diffuses into the area of the rod from which the implant is made. It has been found that it takes at least seven days to diffuse through the surface layer.
  • Free radicals generated during an irradiation step should be reduced to an acceptable level by annealing before exposure to oxygen.
  • the portion of the material from which the implant is made contains free radicals and if it is exposed to air or other oxidants after the manufacturing process, oxidation will occur.
  • the bulk portion of the polymer from which the implant is to be made should be annealed at an elevated temperature while out of contact with oxygen for a prescribed time.
  • an elevated temperature not only increases the reaction rate constants, k 1 and k 2 , but also helps free radicals r. and P. to migrate in the plastic matrix to meet other neighboring free radicals for cross-linking reactions.
  • the desired elevated temperature is between room temperature to below the melting point of the polymer.
  • this temperature range is between about 25° C. and about 140° C. It is to be noted that the higher the temperature used, the shorter the time period needed to combine free radicals.
  • the formed UHMWPE often contains residual (internal) stress caused by incomplete relaxation during the cooling process, which is the last step of the forming process.
  • the annealing process described herein will also help to eliminate or reduce the residual stress.
  • a residual stress contained in a plastic matrix can cause dimensional instability and is in general undesirable.
  • the sequential irradiation followed by sequential annealing after each irradiation is performed in air on a preform such as an extruded rod, bar or compression molded sheet made from polyethylene and preferably UHMWPE.
  • a preform such as an extruded rod, bar or compression molded sheet made from polyethylene and preferably UHMWPE.
  • the final sequential annealing must take place prior to the bulk material of the final part or implant being exposed to air. Normally, it takes at least seven days for atmospheric oxygen to diffuse through the outer layer of polyethylene and deeply enough into rod, bar or sheet to effect the bulk polyethylene forming the final part. Therefore, the last annealing in the sequence preferably should take place prior to the time required for the oxygen to diffuse deeply into the rod.
  • the more material which must be machined off to reach the finished part the longer one can wait for the completion of the sequential irradiation and annealing process.
  • the polymeric component is preferably packaged in an air tight package in an oxidant-free atmosphere, i.e. less than 1% volume by volume.
  • an oxidant-free atmosphere i.e. less than 1% volume by volume.
  • all air and moisture must be removed from the package prior to the sealing step.
  • Machines to accomplish this are commercially available, such as from Orics Industries Inc., College Point, N.Y., which flush the package with a chosen inert gas, vacuum the container, flush the container for the second time, and then heat seal the container with a lid. In general, less than 0.5% (volume by volume) oxygen concentration can be obtained consistently.
  • oxidant impermeable (air tight) packaging material is polyethylene terephthalate (PET).
  • PET polyethylene terephthalate
  • Other examples of oxidant impermeable packaging material is poly(ethylene vinyl alcohol) and aluminum foil, whose oxygen and water vapor transmission rates are essentially zero. All these materials are commercially available.
  • oxidant impermeable packaging material utilize a layer structure to form a composite material with superior oxygen and moisture barrier properties.
  • An example of this type is a layered composite comprised of polypropylene/poly (ethylene vinyl alcohol) /polypropylene.
  • the heat treatment or annealing step should be performed while the implant is out of contact with oxygen or in an inert atmosphere and at an elevated temperature to cause free radicals to form cross-links without oxidation. If proper packaging materials and processes are used and oxidant transmission rates are minimal, then the oxidant-free atmosphere can be maintained in the package and a regular oven with air circulation can be used for heat treatment after sterilization. To absolutely ensure that no oxidants leak into the package, the oven may be operated under a vacuum or purged with an inert gas. In general, if a higher temperature is used, a shorter time period is required to achieve a prescribed level of oxidation resistance and cross-linking. In many cases, the relationship between the reaction temperature and the reaction rate follows the well-known Arrhennius equation:
  • A is a reaction dependent constant
  • T absolute temperature (K).
  • the ultra-high molecular weight polyethylene extruded rod is irradiated for a sufficient time for an accumulated incremental dose of between 2 and 5 (MRads) (20 to 50 kGy).
  • the extruded rod is annealed in air preferably at a temperature below its melting point, preferably at less than 135° C. and more preferably between 110° C. and 130° C.
  • the irradiation and annealing steps are then repeated two or more times so that the total radiation dose is between 4 and 15 MRads (50 to 150 kGy).
  • the rod is irradiated for a total dose of 3 MRad and then annealed at 130° C. for 24 hours, allowed to cool to room temperature and sit for 3 days and then reirradiated for a dose of 3.0 MRads (a total dose of 6 MRads) again annealed at 130° C. for 24 hours, allowed to cool at room temperature and sit for an additional 3 days and then irradiated a third time with a 3.0 MRad dose (for a total of 9 MRads) and again annealed at 130° C. for 24 hours.
  • the rod is cooled to room temperature and is then moved into the manufacturing process which forms the orthopedic implant by machining.
  • the above example can also be applied to compression molded sheet with, for example, a tibial component being manufactured out of the sequentially irradiated and annealed material.
  • the total radiation dose can be anywhere between 5 and 15 MRads and most preferably 9 MRads applied in three doses of 3 MRads, as done in the above example.
  • the length of time between sequential irradiation is preferably between 3 to 7 days.
  • the annealing step is preferably performed after the irradiation step, it is possible to heat the rod to the annealing temperatures and irradiate it sequentially in the heated state.
  • the rod may be allowed to cool between doses or can be maintained at the elevated temperatures for the entire series of doses.
  • a machined tibial implant in its final form is packaged in an oxygen reduced atmosphere having an oxygen concentration less than 1% volume by volume.
  • the packaged implant is then processed as described in Example I through a series of three (3) irradiation and annealing cycles as described above with the total radiation dose being 9 MRads.
  • the implant was then boxed and ready for final shipping and use.
  • Each rod received a nominal dose of 30 kGy gamma radiation
  • Steps 1 and 2 were repeated two more times. Preferably, the repeated steps occurred within three days each.
  • the rods received a nominal 90 kGy total dosage of gamma radiation after the completion of the above sequential process.
  • the GUR 1020 rod is designated as sample “A” and the GUR 1050 rod as sample “B”.
  • sample “A” When done in air, 2 mm of the entire outer surface of each rod is removed after the entire process is complete.
  • Control The following materials/process had been selected as “Control”:
  • Tensile Test The ASTM D 638 Type IV specimens were used for the tensile property evaluation of samples A-E. Tensile properties were determined from the average of six (6) specimens. An Instron Model 4505 Test System was used to conduct this evaluation. Crosshead speed was 5.0 mm/min. The results are listed in Table I.
  • Free Radical Concentration Measurement All free radical measurement was conducted before the accelerated aging treatment. The specimens are 3 mm diameter, 10 mm long cylinders. This evaluation was carried out at the University of Memphis (Physics Department). Free radical concentration was measured and calculated from average of three (3) specimens. Free radical measurements were performed using electron spin resonance technique. This is the only technique that can directly detect free radicals in solid and aqueous media. An ESR spectrometer (Bruker EMX) was used in this evaluation.
  • Oxidation Resistance Measurement Oxidation index/profile measurement was performed after accelerated aging using the protocol per ASTM F 2003 (5 atm O2 pressure at 70° C. for 14 days) on specimens machined into 90 ⁇ 20 ⁇ 10 mm thick rectangular blocks from the center of the rods. The oxidation analysis was performed on a Nicolet model 750 Magna-IRTM spectrometer per ASTM F2102-01 using an aperture 100 ⁇ m ⁇ 100 ⁇ m and 256 scans. An oxidation index was defined by the ratio of the carbonyl peak area (1660 to 1790 cm ⁇ 1 ) to the 1370 cm ⁇ 1 peak area (1330 to 1390 cm ⁇ 1 ).
  • a through-the-thickness (10 mm) oxidation index profile is generated from an average of three (3) specimens.
  • the 0 and 10 mm depths represent upper and lower surfaces of specimens.
  • the maximum oxidation index of each specimen was used to determine if there was a significant difference.
  • the sequential irradiation and annealing process maintains the original tensile yield and ultimate strengths reduces free radical concentration and improves oxidation resistance. It is believed that sequential cross-linking is a gentler process than a single dose process.
  • this process has significant benefits over a single-dose delivery of 90 kGy (non-sequentially) and annealed at 130° C. for 8 hours in at least three areas. First there is a lower free radical concentration, second a better oxidation resistance and third a better tensile elongation.
  • the part may be sterilized via non-irradiative methods such as ethylene oxide or gas plasma and then packaged or repackaged and shipped in the standard manner.
  • GUR 1050 Medical-grade UHMWPE extruded bars
  • the GUR 1050 bars had a total original length of 5 meters and were extruded from the same polymer and extrusion lots. These bars were cut into 460 mm long sections and irradiated with gamma ray at room temperature in ambient air.
  • DSC Differential Scanning Calorimetry
  • results and Discussion The tensile properties (yield strength, ultimate strength and elongation at break) are illustrated in Table 3.
  • the sequential cross-link process increased tensile yield strength following each treatment. This process also maintained ultimate tensile strength in a cross-link UHMWPE while remelt processes significantly decreased both yield and ultimate strengths when comparing to samples that received a 3.0 MRads gamma-radiation in a container with less than 0.5% oxygen.
  • An MTS 8-station hip simulator was used to perform the wear test.
  • the cups were inserted into metal shells as in vivo.
  • the shells were then secured into polyethylene holders that were in turn fitted onto stainless steel spigots.
  • Each head was mounted onto a stainless steel taper that was part of a reservoir containing a fluid serum media.
  • the serum reservoir was mounted on a 23-degree inclined block.
  • a standard physiological cyclic load between two peak loads of 0.64 and 2.5 kN at 1 Hz was applied to all cups. This cyclic load was applied through the central axes of the cup, head and block.
  • the serum used for this test was a fetal-substitute alpha calf fraction serum (ACFS) diluted to a physiologically relevant value of about 20 grams per liter of total protein.
  • a preservative (EDTA) about 0.1 vol. % was added to minimize bacteria degradation.
  • Each reservoir contained about 450 milliliters of abovementioned ACFS with EDTA. This fluid in the reservoir was replaced with fresh ACSS with EDTA every 250,000 cycles. During the fluid replacement process, the samples were removed from the machine, cleaned and weighed.
  • the specimens are 3 mm diameter, 10 mm long cylinders fabricated from abovementioned components. This evaluation was carried out at the University of Memphis (Physics Department, Memphis, Tenn.). Free radical concentration was measured and calculated from an average of three (3) specimens. Free radical measurements were performed using electron spin resonance technique. This is the only technique that can directly detect free radicals in solid and aqueous media. A top-of-the-line ESR spectrometer (Bruker EMX) was used in this evaluation.
  • GUR 1050 received 3.0 MRads 204 ⁇ 14 NA in a container with less than 0.5% oxygen (a reference material)
  • GUR 1050 received 2X 5 ⁇ 1 98 sequentially cross-link and annealed, 6.0 MRads
  • GUR 1050 received 3x 12 ⁇ 1 94 sequentially cross-link and annealed, 9.0 MRads
  • GUR 1050 received 9.0 MRads 67 ⁇ 4 67 cross-link and annealed 130° C. for 8 hours
  • GUR 1050 that received a 9.0 MRads single total dose of cross-link radiation and annealed at 130° for 8 hours.
  • the GUR 1050 materials subjected to the 3X sequential cross-link process also showed a significant reduction in maximum oxidation index by 72% when comparing to a GUR 1050 material that received a 9.0 MRads total dose of gamma-radiation and annealed at 130° C. for 8 hours.
  • TABLE 6 Treatment Maximum Oxidation Index GUR 1050 received 3.0 MRads in a 2.60 ⁇ 0.02 container with less than 0.5% oxygen (a reference material)
  • An oxidation index was defined by the ratio of the carbonyl peak area (1660 to 1790 cm ⁇ 1 ) to the 1370 cm ⁇ 1 peak area (1330 to 1390 cm ⁇ 1 ).
  • a through-the-thickness (about 6 mm) oxidation index profile was generated from an average of three (3) specimens. The 0 and 6 mm depths represented articulating and back surfaces of specimens. The maximum oxidation index of each specimen was used to determine if there was a significant difference.

Abstract

A method of producing an improved polyethylene, especially an ultra-high molecular weight polyethylene utilizes a sequential irradiation and annealing process to form a highly cross-linked polyethylene material. The use of sequential irradiation followed by sequential annealing after each irradiation allows each dose of irradiation in the series of doses to be relatively low while achieving a total dose which is sufficiently high to cross-link the material. The process may either be applied to a preformed material such as a rod or bar or sheet made from polyethylene resin or may be applied to a finished polyethylene part. If applied to a finished polyethylene part, the irradiation and annealing must be accomplished with the polyethylene material not in contact with oxygen at a concentration greater than 1% oxygen volume by volume. When applied to a preform, such as a rod, the annealing of the bulk polymer part of the rod from which the finished part is made must take place on the rod before the implant is machined therefrom and exposed to oxygen.

Description

    CROSS-REFERENCED TO RELATED APPLICATIONS
  • This application is based on U.S. Provisional Application No. 60/386,660 filed on Jun. 6, 2002, the teachings of which are incorporated herein by reference.[0001]
  • BACKGROUND OF THE INVENTION
  • This invention relates to medical implants formed of a polymeric material such as ultra-high molecular weight polyethylene, with superior oxidation and wear resistance produced by a sequential irradiation and annealing process. [0002]
  • Various polymer systems have been used for the preparation of artificial prostheses for biomedical use, particularly orthopedic applications. Among them, ultra-high molecular weight polyethylene is widely used for articulation surfaces in artificial knee, hip, and other joint replacements. Ultra-high molecular weight polyethylene (UHMWPE) has been defined as those linear polyethylenes which have a relative viscosity of 2.3 or greater at a solution concentration of 0.05% at 135° C. in decahydronaphthalene. The nominal weight—average molecular weight is at least 400,000 and up to 10,000,000 and usually from three to six million. The manufacturing process begins with the polymer being supplied as fine powder which is consolidated into various forms, such as rods and slabs, using ram extrusion or compression molding. Afterwards, the consolidated rods or slabs are machined into the final shape of the orthopedic implant components. Alternatively, the component can be produced by compression molding of the UHMWPE resin powder. [0003]
  • All components must then go through a sterilization procedure prior to use, but usually after being packaged. There exists several sterilization methods which can be utilized for medical applications, such as the use of ethylene oxide, gas plasma, heat, or radiation. However, applying heat to a packaged polymeric medical product can destroy either the integrity of the packaging material (particularly the seal, which prevents bacteria from going into the package after the sterilization step) or the product itself. [0004]
  • It has been recognized that regardless of the radiation type, the high energy beam causes generation of free radicals in polymers during radiation. It has also been recognized that the amount or number of free radicals generated is dependent upon the radiation dose received by the polymers and that the distribution of free radicals in the polymeric implant depends upon the geometry of the component, the type of polymer, the dose rate, and the type of radiation beam. The generation of free radicals can be described by the following reaction (which uses polyolefin and gamma ray irradiation for illustration): [0005]
  • gamma rays [0006]
  • Polyolefin ---------------- r. where r. are primary free radicals *  (1)
  • *(through C-C chain scission or C-H scission) [0007]
  • Depending on whether or not oxygen is present, primary free radicals r. will react with oxygen and the polymer according to the following reactions as described in “Radiation Effects on Polymers,” edited by Roger L. Clough and Shalaby W. Shalaby, published by American Chemical Society, Washington, D.C., 1991. [0008]
  • In the presence of oxygen [0009]
  • O2 r.-----------rO2  (2)
  • rO2+polyolefin -------rOOH+P  (3)
  • P.+O0 ---------------- P02.  (4)
  • O2 P02.+polyolefin ---- POOH+P.--------P02.  (5)
  • rO2., P02.------ Some chain scission products room temperature  (6)
  • rOOH, POOH -------------- free radicals, rOH, POH  (7)
  • P.+P02 ------POOP (ester cross-links)  (8)
  • 2 P.------------P-P (C-C cross-links)  (9)
  • In radiation in air, primary free radicals r. will react with oxygen to form peroxyl free radicals r0[0010] 2., which then react with polyolefin (such as UHMWPE) to start the oxidative chain scission reactions (reactions 2 through 6). Through these reactions, material properties of the plastic, such as molecular weight, tensile and wear properties, are degraded.
  • It has been found that the hydroperoxides (rOOH and POOH) formed in [0011] reactions 3 and 5 will slowly break down as shown in reaction 7 to initiate post-radiation degradation. Reactions 8 and 9 represent termination steps of free radicals to form ester or carbon-carbon cross-links. Depending on the type of polymer, the extent of reactions 8 and 9 in relation to reactions 2 through 7 may vary. For irradiated UHMWPE, a value of 0.3 for the ratio of chain scission to cross-linking has been obtained, indicating that even though cross-linking is a dominant mechanism, a significant amount of chain scission occurs in irradiated polyethylene.
  • By applying radiation in an inert atmosphere, since there is no oxidant present, the primary free radicals r. or secondary free radicals P. can only react with other neighboring free radicals to form carbon-carbon cross-links, according to [0012] reactions 10 through 12 below. If all the free radicals react through reactions 10 through 12, there will be no chain scission and there will be no molecular weight degradation. Furthermore, the extent of cross-linking is increased over the original polymer prior to irradiation. On the other hand, if not all the free radicals formed are combined through reactions 10, 11 and 12, then some free radicals will remain in the plastic component.
  • In an Inert Atmosphere [0013]
  • r.+polyolefin ----------- P.  (10)
  • 2 r. ---------- r-r (C-C cross-linking)  (11)
  • 2 P. ---------- P-P (C-C cross-linking)  (12)
  • It is recognized that the fewer the free radicals, the better the polymer retains its physical properties over time. The greater the number of free radicals, the greater the degree of molecular weight and polymer property degradation will occur. Applicant has discovered that the extent of completion of free radical cross-linking reactions is dependent on the reaction rates and the time period given for reaction to occur. [0014]
  • UHMWPE is commonly used to make prosthetic joints such as artificial hip joints. In recent years, it has been found that tissue necrosis and interface osteolysis may occur in response to UHMWPE wear debris. For example, wear of acetabular cups of UHMWPE in artificial hip joints may introduce microscopic wear particles into the surrounding tissues. [0015]
  • Improving the wear resistance of the UHMWPE socket and, thereby, reducing the rate of production of wear debris may extend the useful life of artificial joints and permit them to be used successfully in younger patients. Consequently, numerous modifications in physical properties of UHMWPE have been proposed to improve its wear resistance. [0016]
  • It is known in the art that ultrahigh molecular weight polyethylene (UHMWPE) can be cross-linked by irradiation with high energy radiation, for example gamma radiation, in an inert atmosphere or vacuum. Exposure of UHMWPE to gamma irradiation induces a number of free-radical reactions in the polymer. One of these is cross-linking. This cross-linking creates a 3-dimensional network in the polymer which renders it more resistant to adhesive wear in multiple directions. The free radicals formed upon irradiation of UHMWPE can also participate in oxidation which reduces the molecular weight of the polymer via chain scission, leading to degradation of physical properties, embrittlement and a significant increase in wear rate. The free radicals are very long-lived (greater than eight years), so that oxidation continues over a very long period of time resulting in an increase in the wear rate as a result of oxidation over the life of the implant. [0017]
  • Sun et al. U.S. Pat. No. 5,414,049, the teachings of which are incorporated herein by reference, broadly discloses the use of radiation to form free radicals and heat to form cross-links between the free radicals prior to oxidation. [0018]
  • Hyun et al. U.S. Pat. No. 6,168,626 relates to a process for forming oriented UHMWPE materials for use in artificial joints by irradiating with low doses of high-energy radiation in an inert gas or vacuum to cross-link the material to a low degree, heating the irradiated material to a temperature at which compressive deformation is possible, preferably to a temperature near the melting point or higher, and performing compressive deformation followed by cooling and solidifying the material. The oriented UHMWPE materials have improved wear resistance. Medical implants may be machined from the oriented materials or molded directly during the compressive deformation step. The anisotropic nature of the oriented materials may render them susceptible to deformation after machining into implants. [0019]
  • Salovey et al. U.S. Pat. No. 6,228,900, the teachings of which are incorporated by reference, relates to a method for enhancing the wear-resistance of polymers, including UHMWPE, by cross-linking them via irradiation in the melt. [0020]
  • Saum et al. U.S. Pat. No. 6,316,158 relates to a process for treating UHMWPE using irradiation followed by thermally treating the polyethylene at a temperature greater than 150° C. to recombine cross-links and eliminate free radicals. [0021]
  • Several other prior art patents attempt to provide methods which enhance UHMWPE physical properties. [0022] European Patent Application 0 177 522 81 relates to UHMWPE powders being heated and compressed into a homogeneously melted crystallized morphology with no grain memory of the UHMWPE powder particles and with enhanced modulus and strength. U.S. Pat. No. 5,037,928 relates to a prescribed heating and cooling process for preparing a UHMWPE exhibiting a combination of properties including a creep resistance of less than 1% (under exposure to a temperature of 23° C. and a relative humidity of 50% for 24 hours under a compression of 1000 psi) without sacrificing tensile and flexural properties. U.K. Patent Application GB 2 180 815 A relates to a packaging method where a medical device which is sealed in a sterile bag, after radiation/sterilization, is hermetically sealed in a wrapping member of oxygen-impermeable material together with a deoxidizing agent for prevention of post-irradiation oxidation.
  • U.S. Pat. No. 5,153,039 relates to a high density polyethylene article with oxygen barrier properties. U.S. Pat. No. 5,160,464 relates to a vacuum polymer irradiation process. [0023]
  • SUMMARY OF THE INVENTION
  • The present invention relates to a method for providing a polymeric material, such as UHMWPE, with superior oxidation resistance, mechanical strength and wear properties. For the purpose of illustration, UHMWPE will be used as an example to describe the invention. However, all the theories and processes described hereafter should also apply to other polymeric materials such as polypropylene, high density polyethylene, polyhydrocarbons, polyester, nylon, polyurethane, polycarbonates and poly(methylmethcrylate) unless otherwise stated. The method involves using a series of relatively low doses of radiation with an annealing process after each dose. [0024]
  • As stated above, UHMWPE polymer is very stable and has very good resistance to aggressive media except for strong oxidizing acids. Upon irradiation, free radicals are formed which cause UHMWPE to become activated for chemical reactions and physical changes. Possible chemical reactions include reacting with oxygen, water, body fluids, and other chemical compounds while physical changes include density, crystallinity, color, and other physical properties. In the present invention, the sequential radiation and annealing process greatly improves the physical properties of UHMWPE when compared to applying the same total radiation dose in one step. Furthermore, this process does not employ stabilizers, antioxidants, or any other chemical compounds which may have potentially adverse effects in biomedical or orthopedic applications. [0025]
  • It is also known that at relatively low dose levels (<5 MRads) of irradiation residual free radicals are mostly trapped in the crystalline region while most free radicals crosslink in the amorphous region. There is a steep free radical concentration gradient across the crystalline-amorphous boundary, which provides a significant driving force for free radicals to diffuse into the amorphous region where they can crosslink upon subsequent annealing. However, if the polyethylene is allowed to continuously accumulate higher radiation doses without interruptive annealing, molecules in the amorphous region become more and more stiffened due to increased crosslinking. As a result, the amorphous region traps more and more free radicals. This leads to a diminished free radical gradient across the crystalline-amorphous boundary, thereby reducing the driving force for free radical diffusion upon subsequent annealing. By limiting the incremental dose to below 5 MRads and preferably below 3.5 MRads and following with annealing, a relatively higher free radical diffusion driving force can be maintained, allowing a more efficient free radical reduction upon annealing. If higher radiation doses are used, there could be cross-linking at the chain folded crystal surfaces. This could hamper the movement of free radicals from the crystal to the amorphous regions. [0026]
  • It has been found that polyethylene crystallinity increases continuously with increasing radiation-doses due to chain-scission (approximately 55% before radiation, increasing to 60% at 3.0 MRads, and to 65% at 10 MRads). [0027]
  • As the crystallinity increases with increasing dose of radiation, more residual free radicals are created and stored in the extra crystalline regions, which makes it increasingly more difficult to eliminate free radicals by annealing below the melt temperature. However, treating above the melting temperature (re-melting) significantly alters the crystallinity and crystal morphology which leads to significant reduction in mechanical properties such as yield strength and ultimate tensile strength and creep resistance and these properties are important for the structural integrity of the implant. [0028]
  • An orthopedic preformed material such as a rod, bar or compression molded sheet for the subsequent production of a medical implant such as an acetabular or tibial implant with improved wear resistance is made from a polyethylene material cross-linked at least twice by irradiation and thermally treated by annealing after each irradiation. The material is cross-linked by a total radiation dose of from about 2 MRads to 100 MRads and preferably between 5 MRads and 10 MRads. The incremental dose for each irradiation is between about 2 MRads and about 5 MRads. The weight average molecular weight of the material is over 400,000. [0029]
  • The annealing takes place at a temperature greater than 25° C., preferably between 110° C. and 135° C. but less than the melting point. Generally, the annealing takes place for a time and temperature selected to be at least equivalent to heating the irradiated material at 50° C. for 144 hours as defined by Arrenhius' equation 14. The material is heated for at least about 4 hours and then cooled to room temperature for the subsequent irradiation in the series. [0030]
  • By limiting the incremental dose to below 5 MRads and preferably below 3.5 MRads and following with annealing, the crystallinity will fluctuate between 55% and 60% (instead of 55-65%) and hence both the amount of chain-scission and residual free-radical concentration can be significantly reduced. [0031]
  • The polyethylene of the present invention may be in the form of a preformed rod or sheet with a subsequent production of a medical implant with improved wear resistance. The preformed rod or sheet is cross-linked at least twice by irradiation and thermally treated by annealing after each radiation. The incremental dose for each radiation is preferably between about 2 and 5 MRads with the total dose between 2 and 100 MRads and preferably between 5 and 10 MRads. [0032]
  • After each irradiation, the preformed material is annealed either in air or in an inner atmosphere at a temperature of greater than 25° C. and preferably less than 135° C. or the melting point. Preferably, the annealing takes place for a time and temperature selected to be at least equivalent to heating the irradiated material at 50° C. for 144 hours as defined by Arrenhius' equation (14). Generally, each heat treatment lasts for at least 4 hours and preferably about 8 hours. [0033]
  • The preformed polyethylene material is then machined into a medical implant or other device. If the irradiation process occurred in air, then the entire outer skin to about 2 mm deep is removed from the preform prior to machining the medical implant or other device. If the process was done in a vacuum or an inner atmosphere such a nitrogen, then the outer skin may be retained. [0034]
  • The end-results of reduced chain-scission and free-radical concentration are improved mechanical properties, improved oxidation resistance and enhanced wear resistance.[0035]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows the oxidation index profiles of the specimens of Example 8; and [0036]
  • FIG. 2 shows the oxidation index profiles of the specimens of Example 11.[0037]
  • DETAILED DESCRIPTION
  • Abbreviations used in this application are as follows: [0038]
  • UHMW—ultra-high molecular weight [0039]
  • UHMWPE—ultra-high molecular weight polyethylene [0040]
  • HMW—high molecular weight [0041]
  • HMWPE—high molecular weight polyethylene [0042]
  • This invention provides a method for improving the wear resistance of a polymer by crosslinking (preferably the bearing surface of the polymer) and then thermally treating the polymer, and the resulting polymer. Preferably, the most oxidized surface of the polymer is also removed. Also presented are the methods for using the polymeric compositions for making products and the resulting products, e.g., in vivo implants. [0043]
  • The method of the invention utilizes at least two separate irradiations for crosslinking a polymer followed by a like number of thermal treatments to decrease the free radicals to produce either a treated fully formed or a preformed polymeric composition. The term “preformed polymeric composition” means that the polymeric composition is not in a final desired shape or from (i.e., not a final product). For example, where the final product of the preformed polymeric composition is an acetabular cup, the at least two irradiations and thermal treatments of the polymer could be performed at pre-acetabular cup shape, such as when the preformed polymeric composition is in the form of a solid bar or block. Of course, the process of the present invention could be applied to a fully formed implant if the process is done with the implant in an oxygen reduced atmosphere. [0044]
  • In the present invention, the wear resistance of a polymer is improved by crosslinking. The crosslinking can be achieved by various methods known in the art, for example, by irradiation from a gamma radiation source or from an electron beam, or by photocrosslinking. The preferred method for crosslinking the polymer is by gamma irradiation. The polymer is preferably crosslinked in the form of an extruded bar or molded block. [0045]
  • In the preferred method, the crosslinked polymer is subjected to thermal treatment such as by annealing (i.e. heated above at or below the melting temperature of the crosslinked polymer) to produce the preformed polymeric composition. [0046]
  • In the preferred embodiment of the invention, the outer layer of the resulting preformed polymeric composition, which is generally the most oxidized and least crosslinked and, thus, least wear resistant, is removed. For example, the bearing surface of the preformed polymeric composition may be fashioned from inside, e.g., by machining away the surface of the irradiated and thermally treated composition before or during fashioning into the final product, e.g., into an implant. Bearing surfaces are surfaces which are in moving contact, e.g., in a sliding, pivoting, or rotating relationship to one another. [0047]
  • High molecular weight (HMW) and ultra-high molecular weight (UHMW) polymers are preferred, such as HMW polyethylene (HMWPE), UHMW polyethylene (UHMWPE), and UHMW polypropylene. HMW polymers have molecular weights ranging from about 10[0048] 5 grams per mole to just below 106. UHMW polymers have molecular weights equal to or higher than 106 grams per mole, preferably from 106 to about 107. The polymers are generally between about 400,000 grams per mole to about 10,000,000 and are preferably polyolefinic materials.
  • For implants, the preferred polymers are those that are wear resistant and have exceptional chemical resistance. UHMWPE is the most preferred polymer as it is known for these properties and is currently widely used to make acetabular cups for total hip prostheses and components of other joint replacements. Examples of UHMWPE are those having molecular weight ranging from about 1 to 8×10[0049] 6 grams per mole, examples of which are: GUR 1150 or 1050 (Hoechst-Celanese Corporation, League City, Tex.) with a weight average molecular weight of 5 to 6×106 grams per mole; GUR 1130 with a weight average molecular weight of 3 to 4×106; GUR 1120 or 1020 with a weight average molecular weight of 3 to 4×106; RCH 1000 (Hoechst-Celanese Corp.) with a weight average of molecular weight of 4×106 and HiFax 1900 of 2 to 4×106 (HiMont, Elkton, Md.). Historically, companies which make implants have used polyethylenes such as HIFAX 1900, GUR 1020, GUR 1050, GUR 1120 and GUR 1150 for making acetabular cups.
  • Sterilization Methods: All polymeric products must be sterilized by a suitable method prior to implanting in the human body. For the formed crosslinked and thermally treated polymeric compositions (i.e., the final products) of the present invention, it is preferable that the products be sterilized by a non-radiation based method, such as ethylene oxide or gas plasma, in order not to induce additional crosslinking free radicals and/or oxidation of the previously treated preformed polymeric composition. Compared to radiation sterilization, a non-radiation sterilization method has a minor effect on the other important physical characteristics of the product. [0050]
  • The degree of crystallinity can be determined using methods known in the art, e.g. by differential scanning calorimetry (DSC), which is generally used to assess the crystallinity and melting behavior of a polymer. Wang, X. & Salovey, R., [0051] J. App. Polymer Sci., 34:593-599 (1987).
  • Wide-angle X-ray scattering from the resulting polymer can also be used to further confirm the degree of crystallinity of the polymer, e.g. as described in Spruiell, J. E., & Clark, E. S., in “[0052] Methods of Experimental-Physics,” L. Marton & C. Marton, Eds., Vol. 16, Part B, Academic Press, New York (1980). Other methods for determining the degree of crystallinity of the resulting polymer may include Fourier Transform Infrared Spectroscopy (FTIR), e.g., as described in “Fourier Transform Infrared Spectroscopy And Its Application To Polymeric Materials,” John Wiley and Sons, New York, U.S.A. (1982)} and density measurement (ASTM D1505-68). Measurements of the gel content and swelling are generally used to characterize crosslink distributions in polymers; the procedure is described in Ding, Z. Y., et al., J. Polymer Sci., Polymer Chem., 29:1035-38 (1990). FTIR can also be used to assess the depth profiles of oxidation as well as other chemical changes such as unsaturation {Nagy, E. V. & Li, S., “A Fourier transform infrared technique for the evaluation of polyethylene orthopedic bearing materials,” Trans. Soc. for Biomaterials, 13:109 (1990); Shinde, A. & Salovey, R., J. Polymer Sci., Polm. Phys. Ed., 23:1681-1689 (1985)}.
  • Another aspect of the invention presents a process for making implants using the preformed polymeric composition of the present invention. The preformed polymeric composition may be shaped, e.g., machined, into the appropriate implants using methods known in the art. Preferably, the shaping process, such as machining, removing the oxidized surface of the composition. [0053]
  • The preformed polymeric compositions of the present invention can be used in any situation where a polymer, especially UHMWPE, is called for, but especially in situations where high wear resistance is desired. More particularly, these preformed polymeric compositions are useful for making implants. [0054]
  • An important aspect of this invention presents implants that are made with the above preformed polymeric compositions or according to the methods presented herein. In particular, the implants are produced from preformed polymeric composition made of UHMWPE irradiated and crosslinked at least twice each time followed by annealing and then removing the oxidized surface layer and then fabricating into a final shape. The preformed polymeric composition of the present invention can be used to make the acetabular cup, or the insert or liner of the cup, or trunnion bearings (e.g. between the modular head and the hip stem). In the knee joint, the tibial plateau (femoro-tibial articulation), the patellar button (patello-femoral articulation), and/or other bearing components, depending on the design of the artificial knee joint. These would include application to mobile bearing knees where articulation between the tibial insert and tibial tray occurs. In the shoulder, the process can be used in the glenoid component. In the ankle joint, the preformed polymeric composition can be used to make the talar surface (tibiotalar articulation) and other bearing components. In the elbow joint, the preformed polymeric composition can be used to make the radio-humeral joint, ulno-humeral joint, and other bearing components. In the spine, the preformed polymeric composition can be used to make intervertebral disk replacement and facet joint replacement. The preformed polymeric composition can also be made into temporo-mandibular joint (jaw) and finger joints. The above are by way of example, and are not meant to be limiting. [0055]
  • The following discusses the first and second aspects of the invention in more detail. [0056]
  • First Aspect of the Invention: Polymeric Compositions with Increased Wear Resistance. [0057]
  • The first aspect of the invention provides preformed polymeric compositions which are wear resistant and useful for making in vivo implants. In this aspect, for polymers in general, and more preferably UHMW and HMW polymers, and most preferably UHMWPE and HMWPE, the at least two (2) incremental irradiation doses are preferably from about 1 to about 100 Mrad, and more preferably, from about 2 to about 5 Mrad. This most preferable range is based on achieving a reasonable balance between improved wear resistance and minimal degradation of other important physical properties. The total dose is between 2 and 100 MRad and more preferably 5 to about 10 MRads. [0058]
  • In vivo implants of the present invention, i.e., irradiated within the above dose ranges are expected to function in vivo without mechanical failure. The UHMWPE acetabular cups used by Oonishi et al. [in [0059] Radiat. Phys. Chem., 39:495-504 (1992)] were irradiated to 100 Mrad and functioned in vivo without reported mechanical failure as long as 26 years of clinical use. Furthermore, it is surprising that, as shown in the EXAMPLES, acetabular cups from the preformed polymeric composition prepared according to the present invention, but irradiated to much less than 100 Mrad, exhibited much higher wear resistance than reported by Oonishi et al.
  • On the other hand, if a user is primarily concerned with reducing wear, and other physical properties are of secondary concern, then a higher dose than the above stipulated most preferable range (e.g., 5 to 10 Mrad) may be appropriate, or vice versa (as illustrated in the detailed examples in the following section). The optimum radiation dose is preferably based on the total dose received at the level of the bearing surface in the final product. Gamma radiation is preferred. [0060]
  • The preferred annealing temperature after each sequential irradiation is below the melting temperature of the UHMWPE which is generally below 135° C. [0061]
  • The annealing temperature is preferably from about room temperature to below the melting temperature of the irradiated polymer; more preferably from about 90° C. to about 1° C. below the melting temperature of the irradiated polymer; and most preferably from about 110° C. to about 130° C. For example, UHMWPE may be annealed at a temperature from about 25° C. to about 140° C., preferably from about 50° C. to about 135° C. and more preferably from about 80° C. to about 135° C. and most preferably between 110° C. to 130° C. The annealing period is preferably from about 2 hours to about 7 days, and more preferably from about 7 hours to about 5 days and most preferably from about 10 hours to about 24 hours. [0062]
  • Instead of using the above range of radiation dose as a criterion, the appropriate amount of crosslinking may be determined based on the degree of swelling, gel content, or molecular weight between crosslinks after thermal treatment. This alternative is based on the applicant's findings (detailed below) that acetabular cups made from UHMWPE falling within a preferred range of these physical parameters have reduced or non-detectable wear. The ranges of these physical parameters include one or more of the following: a degree of swelling of between about 1.7 to about 5.3; molecular weight between crosslinks of between about 400 to about 8400 g/mol; and a gel content of between about 95% to about 99%. A preferred polymer or final product has one or more, and preferably all, of the above characteristics. These parameters can also be used as starting points in the second aspect of the invention (as illustrated by the flowchart, discussed below) for determining the desired radiation dose to balance the improvement in wear resistance with other desired physical or chemical properties, such as polymer strength or stiffness. [0063]
  • After crosslinking and thermal treatment, preferably, the most oxidized surface of the preformed polymeric composition is removed. The depth profiles of oxidation of the preformed polymeric composition can be determined by methods known in the art, such as FTIR. In general, the most oxidized surface of preformed polymeric composition which is exposed to air is removed, e.g. by machining, before or while fashioning the preformed polymeric composition into the final product. Since oxygen diffuses through the polyethylene with time, the sequential irradiation/annealing preferably should be completed prior to oxygen diffusing in high concentrations to the area of the preform from which the final part is made. [0064]
  • As noted above, the most preferable range of total dose for crosslinking radiation (i.e., from 5 to 10 Mrad) was based on Wang et al. “Tribology International” Vol. 3, No. 123 (1998) pp. 17-35. After irradiation in air the gap in time before annealing is preferably seven days but at least before any oxygen diffuses into the area of the rod from which the implant is made. It has been found that it takes at least seven days to diffuse through the surface layer. [0065]
  • Free radicals generated during an irradiation step should be reduced to an acceptable level by annealing before exposure to oxygen. The portion of the material from which the implant is made contains free radicals and if it is exposed to air or other oxidants after the manufacturing process, oxidation will occur. The bulk portion of the polymer from which the implant is to be made should be annealed at an elevated temperature while out of contact with oxygen for a prescribed time. This is because the rate of free radical reactions ([0066] reactions 10 through 12) increases with increasing temperature, according to the following general expressions: r t = k 1 [ r ] and P t = k 2 [ P ] ( 13 )
    Figure US20030229155A1-20031211-M00001
  • Compared to room temperature, an elevated temperature not only increases the reaction rate constants, k[0067] 1 and k2, but also helps free radicals r. and P. to migrate in the plastic matrix to meet other neighboring free radicals for cross-linking reactions. In general, the desired elevated temperature is between room temperature to below the melting point of the polymer. For UHMWPE, this temperature range is between about 25° C. and about 140° C. It is to be noted that the higher the temperature used, the shorter the time period needed to combine free radicals. Additionally, due to the high viscosity of a UHMWPE melt, the formed UHMWPE often contains residual (internal) stress caused by incomplete relaxation during the cooling process, which is the last step of the forming process. The annealing process described herein will also help to eliminate or reduce the residual stress. A residual stress contained in a plastic matrix can cause dimensional instability and is in general undesirable.
  • In the preferred embodiment, the sequential irradiation followed by sequential annealing after each irradiation is performed in air on a preform such as an extruded rod, bar or compression molded sheet made from polyethylene and preferably UHMWPE. Obviously, the final sequential annealing must take place prior to the bulk material of the final part or implant being exposed to air. Normally, it takes at least seven days for atmospheric oxygen to diffuse through the outer layer of polyethylene and deeply enough into rod, bar or sheet to effect the bulk polyethylene forming the final part. Therefore, the last annealing in the sequence preferably should take place prior to the time required for the oxygen to diffuse deeply into the rod. Of course, the more material which must be machined off to reach the finished part, the longer one can wait for the completion of the sequential irradiation and annealing process. [0068]
  • If the sequential irradiation/annealing process is performed on a final product, such as an acetabular cup, after machining, the polymeric component is preferably packaged in an air tight package in an oxidant-free atmosphere, i.e. less than 1% volume by volume. Thus, all air and moisture must be removed from the package prior to the sealing step. Machines to accomplish this are commercially available, such as from Orics Industries Inc., College Point, N.Y., which flush the package with a chosen inert gas, vacuum the container, flush the container for the second time, and then heat seal the container with a lid. In general, less than 0.5% (volume by volume) oxygen concentration can be obtained consistently. An example of a suitable oxidant impermeable (air tight) packaging material is polyethylene terephthalate (PET). Other examples of oxidant impermeable packaging material is poly(ethylene vinyl alcohol) and aluminum foil, whose oxygen and water vapor transmission rates are essentially zero. All these materials are commercially available. Several other suitable commercial packaging materials utilize a layer structure to form a composite material with superior oxygen and moisture barrier properties. An example of this type is a layered composite comprised of polypropylene/poly (ethylene vinyl alcohol) /polypropylene. [0069]
  • With a final product, following each irradiation step, the heat treatment or annealing step should be performed while the implant is out of contact with oxygen or in an inert atmosphere and at an elevated temperature to cause free radicals to form cross-links without oxidation. If proper packaging materials and processes are used and oxidant transmission rates are minimal, then the oxidant-free atmosphere can be maintained in the package and a regular oven with air circulation can be used for heat treatment after sterilization. To absolutely ensure that no oxidants leak into the package, the oven may be operated under a vacuum or purged with an inert gas. In general, if a higher temperature is used, a shorter time period is required to achieve a prescribed level of oxidation resistance and cross-linking. In many cases, the relationship between the reaction temperature and the reaction rate follows the well-known Arrhennius equation: [0070]
  • k1 or k2=A * exp (−ΔH/T)  (14)
  • where k[0071] 1 and k2 are reaction rate constants from reactions 13 and 14
  • A is a reaction dependent constant [0072]
  • ΔH is activation energy of reaction [0073]
  • T is absolute temperature (K). [0074]
  • It is very important to ensure that the number of free radicals has been reduced to a minimal or an accepted level by the heat treatment. This is because the presence of an oxidant causes not only the oxidation of pre-existing free radicals, but also the formation of new free radicals via [0075] reactions 2 through 7. When the number of free radicals grows, the extent of oxidation and the oxidation rate will increase according to the following equations: r t = k 3 [ r ] [ O 2 ] and P• t = k 4 [ P ] [ O 2 ] ( 15 )
    Figure US20030229155A1-20031211-M00002
  • Where free radicals r. and P. can grow in number in the presence of oxidants and in turn increase the oxidation rates. It is also to be noted that the oxidation reaction rate constants k[0076] 3 and k4 increase with increasing temperature, similar to k1 and k2. Therefore, to determine if a certain level of residual free radicals is acceptable or not, it is required to evaluate specific material properties after the plastic sample is stored or aged at the application temperature for a time period which is equal to or longer than the time period intended for the application of the plastic component. An alternative to the method to assess the aging effect is to raise the aging temperature of the plastic sample for a shorter time period. This will increase the reaction rate constants k3 and k4 significantly and shorten the aging time. It has been found that an acceptable level of residual free radicals is 1.0×1017/g for UHMWPE use for orthopedic implants.
  • EXAMPLE I
  • As stated above, the ultra-high molecular weight polyethylene extruded rod is irradiated for a sufficient time for an accumulated incremental dose of between 2 and 5 (MRads) (20 to 50 kGy). After this irradiation step, the extruded rod is annealed in air preferably at a temperature below its melting point, preferably at less than 135° C. and more preferably between 110° C. and 130° C. The irradiation and annealing steps are then repeated two or more times so that the total radiation dose is between 4 and 15 MRads (50 to 150 kGy). In this example, the rod is irradiated for a total dose of 3 MRad and then annealed at 130° C. for 24 hours, allowed to cool to room temperature and sit for 3 days and then reirradiated for a dose of 3.0 MRads (a total dose of 6 MRads) again annealed at 130° C. for 24 hours, allowed to cool at room temperature and sit for an additional 3 days and then irradiated a third time with a 3.0 MRad dose (for a total of 9 MRads) and again annealed at 130° C. for 24 hours. The rod is cooled to room temperature and is then moved into the manufacturing process which forms the orthopedic implant by machining. [0077]
  • The above example can also be applied to compression molded sheet with, for example, a tibial component being manufactured out of the sequentially irradiated and annealed material. [0078]
  • In the preferred embodiment, the total radiation dose can be anywhere between 5 and 15 MRads and most preferably 9 MRads applied in three doses of 3 MRads, as done in the above example. The length of time between sequential irradiation is preferably between 3 to 7 days. While the annealing step is preferably performed after the irradiation step, it is possible to heat the rod to the annealing temperatures and irradiate it sequentially in the heated state. The rod may be allowed to cool between doses or can be maintained at the elevated temperatures for the entire series of doses. [0079]
  • EXAMPLE II
  • A machined tibial implant in its final form is packaged in an oxygen reduced atmosphere having an oxygen concentration less than 1% volume by volume. The packaged implant is then processed as described in Example I through a series of three (3) irradiation and annealing cycles as described above with the total radiation dose being 9 MRads. The implant was then boxed and ready for final shipping and use. [0080]
  • EXAMPLE III
  • Two ultra-high molecular weight polyethylene rods (one of compression molded GUR 1020 and the other of ram extruded GUR 1050) with a cross-section profile of 2.5-inch×3.5-inch (GUR 1020) and 3.5-inch diameter (GUR 1050), respectively, were used. Lengths of these rods were sectioned into 18-inch lengths; three 18-inch rods (staggered and separated by small paper boxes) were packaged in a paper carton before the sequential radiation process. The purpose of the packaging and staggering was to reduce the possibility of blocking the radiation (gamma rays) to each individual rod during the process. [0081]
  • The rods went through the following sequential process in air: [0082]
  • 1. Each rod received a nominal dose of 30 kGy gamma radiation; [0083]
  • 2. Each was then annealed at 130° C. for 8 hours; and [0084]
  • 3. [0085] Steps 1 and 2 were repeated two more times. Preferably, the repeated steps occurred within three days each.
  • While the process was done in air, it could be performed in an inert atmosphere such as nitrogen. [0086]
  • The rods received a nominal 90 kGy total dosage of gamma radiation after the completion of the above sequential process. The GUR 1020 rod is designated as sample “A” and the GUR 1050 rod as sample “B”. When done in air, 2 mm of the entire outer surface of each rod is removed after the entire process is complete. [0087]
  • Control—The following materials/process had been selected as “Control”: [0088]
  • 1. The conventionally (in nitrogen or vacuum N[0089] 2VAC) processed molded GUR 1020 and extruded GUR 1050 rods received in a single dose 30 kGy gamma radiation sterilization in nitrogen but no annealing and were designated samples “C” and “D,” respectively.
  • 2. A GUR 1050 rod that received 90 kGy total dose (non-sequentially) followed by annealing at 130° C. for 8 hours and was designated as sample “E”. [0090]
  • Tensile Test—The ASTM D 638 Type IV specimens were used for the tensile property evaluation of samples A-E. Tensile properties were determined from the average of six (6) specimens. An Instron Model 4505 Test System was used to conduct this evaluation. Crosshead speed was 5.0 mm/min. The results are listed in Table I. [0091]
  • Free Radical Concentration Measurement—All free radical measurement was conducted before the accelerated aging treatment. The specimens are 3 mm diameter, 10 mm long cylinders. This evaluation was carried out at the University of Memphis (Physics Department). Free radical concentration was measured and calculated from average of three (3) specimens. Free radical measurements were performed using electron spin resonance technique. This is the only technique that can directly detect free radicals in solid and aqueous media. An ESR spectrometer (Bruker EMX) was used in this evaluation. [0092]
  • Oxidation Resistance Measurement—Oxidation index/profile measurement was performed after accelerated aging using the protocol per ASTM F 2003 (5 atm O2 pressure at 70° C. for 14 days) on specimens machined into 90×20×10 mm thick rectangular blocks from the center of the rods. The oxidation analysis was performed on a Nicolet model 750 Magna-IR™ spectrometer per ASTM F2102-01 using an aperture 100 μm×100 μm and 256 scans. An oxidation index was defined by the ratio of the carbonyl peak area (1660 to 1790 cm[0093] −1) to the 1370 cm−1 peak area (1330 to 1390 cm−1). A through-the-thickness (10 mm) oxidation index profile is generated from an average of three (3) specimens. The 0 and 10 mm depths represent upper and lower surfaces of specimens. The maximum oxidation index of each specimen was used to determine if there was a significant difference.
  • Statistical Analysis—Student's t Test—Test of Significance—A student's t test (two-tail, unpaired) was conducted to measure statistical significance at the 95% confidence level (p<0.05). [0094]
  • Tensile Test Results [0095]
    TABLE 1
    Comparison Of Tensile Properties, N = 6
    Yield Ultimate
    Strength Strength Elongation at
    Sample Material (MPa) (MPa) Break (%)
    A GUR 1020 24.9 ± 0.6 59.3 ± 1.5 301 ± 7
    B GUR 1050 25.6 ± 0.4 54.8 ± 1.2 255 ± 7
    C GUR 1020 25.2 ± 0.1 57.0 ± 2.3  372 ± 10
    D GUR 1050 24.5 ± 0.2 56.4 ± 4.0  370 ± 10
    E GUR 1050 23.9 ± 0.4 51.0 ± 2.1 214 ± 5
  • The sequential process of samples “A” and “B” maintains both tensile yield and ultimate strength (when compared to their respective counterparts samples C and D). Consequently, the null hypothesis that sequential process maintains (p=0.001) tensile strengths was verified. Results also indicated that a sequential process improved elongation at break in radiation-crosslinked GUR 1050 by 19% (p=0.001) over a process that produced crosslinking by a single-dose delivery of 90 kGy (non-sequentially) and annealed at 130° C. for 8 hours (sample E). [0096]
  • The sequential crosslinking reduces free radical concentration in radiation-crosslinked GUR 1020 and 1050 by 87% (p=0.001) and 94% (p=0.001), respectively when comparing to their respective N2VAC™ process counterparts, samples C and D. The sequential crosslinking process also reduces free radical concentration in radiation-crosslinked GUR 1050 by 82% (p=0.001) over a process that produced crosslinking by a single-dose delivery of 90 kGy (non-sequentially) and annealed at 130° C. for 8 hours (sample E). [0097]
  • The sequential crosslinking process reduces the maximum oxidation index in radiation crosslinked GUR 1020 and 1050 by 82% (p=0.001) and 86% (p=0.001), respectively (when compared to control samples C and D). The process also reduces the maximum oxidation index in radiation-crosslinked GUR 1050 by 74% (p=0.001) over a process that produced crosslinking by a single-dose delivery of 90 kGy (non-sequentially) and annealed at 130° C. for at least 8 hours (sample E). The sequential irradiation and annealing process maintains the original tensile yield and ultimate strengths reduces free radical concentration and improves oxidation resistance. It is believed that sequential cross-linking is a gentler process than a single dose process. [0098]
  • Furthermore, this process has significant benefits over a single-dose delivery of 90 kGy (non-sequentially) and annealed at 130° C. for 8 hours in at least three areas. First there is a lower free radical concentration, second a better oxidation resistance and third a better tensile elongation. [0099]
  • While the preferred process is three sequential applications of 30 kGy each followed by annealing at 130° C. for eight (8) hours, a two step process of 30 kGy to 45 kGy radiation applied twice, each followed by an annealing at about 130° C. for about 8 hours may be used. [0100]
  • If it is desired to have an additional sterilization step after the sequential irradiation and annealing of the ultra-high molecular weight polyethylene preformed part or packaged final part then the part may be sterilized via non-irradiative methods such as ethylene oxide or gas plasma and then packaged or repackaged and shipped in the standard manner. [0101]
  • EXAMPLE IV Effect of Sequential Cross-Link Dose on the Physical Properties of UHMWPE
  • Materials and Methods—Medical-grade UHMWPE extruded bars (GUR 1050, Perplas Medical), with a weight average molecular weight of 5×10[0102] 6 Daltons and a diameter of 83 mm were used for all subsequent treatments. The GUR 1050 bars had a total original length of 5 meters and were extruded from the same polymer and extrusion lots. These bars were cut into 460 mm long sections and irradiated with gamma ray at room temperature in ambient air.
  • The treatments of these materials are listed in Table 3. The terminologies 1X means a single cycle of irradiation and annealing and 2X and 3X denote that the materials received the sequential cross-link process, two and three times, respectively; these materials received a nominal dose of 3.0 MRads during each step of radiation. Annealing was done at 130° C. for 8 hours after each radiation dose. [0103]
  • Differential Scanning Calorimetry (DSC)—DSC samples were cut from machined 1 mm thick sheets. Specimens (˜4 mg) were heated from 50° C. at heating rate of 10 C./min in a Perkin-[0104] Elmer DSC 7 to 175°C. The melting temperature was determined from the peak of the melting endotherm. The heat of fusion was calculated through an integration of the area under the melting endotherm between 60° C. and 145° C. Crystallinity was calculated using the abovementioned heat of fusion divided by 288 J/g, the heat of fusion of an ideal polyethylene crystal.
  • Results and Discussion—The measured melting temperature and crystallinity are listed in Table 2. After the three consecutive sequential cross-link process; materials received 3.0, 6.0 and 9.0 MRads total gamma-radiation showed no change in crystallinity when comparing to material that received a 3.0 MRads gamma-radiation in a container with less than 0.5% oxygen (58% v 57.6%) while remelting caused a significant decrease in crystallinity from 57% to 48%. [0105]
    TABLE 2
    Melting Temperature, Crystallinity,
    Treatment ° C. %
    No Radiation 135.8 ± 0.1 54.3 ± 0.7
    3.0 MRads single dose in a 139.9 ± 0.2 57.6 ± 0.8
    Container with less than
    0.5% oxygen
    1X cross-linked and 140.1 ± 0.2 56.7 ± 0.9
    annealed one time,
    3.0 MRads
    2X sequentially cross-link 141.1 ± 0.1 57.4 ± 0.6
    and annealed, 6.0 MRads
    3X sequentially cross-link 142.3 ± 0.1 58.0 ± 0.9
    and annealed, 9.0 MRads
    5 MRads single dose 137.0 ± 0.2 48.2 ± 0.7
    cross-link, remelted at
    150° C. for 8 hours
    10 MRads single dose 139.7 ± 0.2 48.6 ± 0.6
    cross-link, remelted at
    150° C. for 8 hours
  • EXAMPLE V Effect of Sequential Cross-link Dose on the Tensile Properties of UHMWPE
  • Materials and Methods—The materials for tensile property evaluation are the same as the physical property materials described in Example IV above. Six tensile specimens were machined out of the center of the 83 mm diameter bars according to ASTM F648, Type IV and 1 mm thick. Tensile property evaluation was carried out on an electromechanical Instron model 4505 universal test frame at a speed of 50 mm/inch. The treatments of these materials are listed in Table 2. [0106]
  • Results and Discussion—The tensile properties (yield strength, ultimate strength and elongation at break) are illustrated in Table 3. The sequential cross-link process increased tensile yield strength following each treatment. This process also maintained ultimate tensile strength in a cross-link UHMWPE while remelt processes significantly decreased both yield and ultimate strengths when comparing to samples that received a 3.0 MRads gamma-radiation in a container with less than 0.5% oxygen. [0107]
    TABLE 3
    Yield Strength Ultimate Elongation at
    Treatment (MPa) Strength (MPa) Break (%)
    No radiation 21.4 ± 0.5 52.2 ± 3.1 380 ± 18
    3.0 MRads single 24.5 ± 0.2 54.6 ± 4.0 356 ± 14
    dose in a container
    with less than 0.5%
    oxygen
    1x cross-link and 22.7 ± 0.2 50.4 ± 2.8 338 ± 10
    annealed, a single
    time 3.0 MRads
    2X sequentially 23.5 ± 0.5 52.2 ± 3.9 299 ± 11
    cross-link and
    annealed, 6.0 MRads
    total dose
    3X sequentially 25.6 ± 0.4 54.8 ± 1.2 255 ± 7 
    cross-link and
    annealed, 9.0 MRads
    total dose
    5 MRads single dose 21.3 ± 0.3 48.2 ± 3.1 297 ± 8 
    cross-link,
    remelted at 150° C.
    for 8 hours
    10 MRads single 21.6 ± 0.4 43.6 ± 0.7 260 ± 12
    dose cross-link
    remelted at 150° C.
    for 8 hours
  • EXAMPLE VI Effect of Sequential Cross-link Dose on the Wear Properties of UHMWPE Acetabular Cups
  • Materials and Methods—Two types of UHMWPE materials, ram extruded GUR 1050 bars (83 mm diameter) and compression molded GUR 1020 sheets (51 mm×76 mm cross-section were treated). The sequential cross-link process was performed on the GUR 1050 materials either 2 or 3 times and on GUR 1020 [0108] material 3 times only. The nominal radiation dose for each radiation/annealing cycle was 3.0 MRads. A current standard product, Trident™ design 32 mm acetabular cup (manufactured by Howmedica Osteonics Corp. from GUR 1050 bar stock) sterilized under a 3.0 MRads gamma-radiation in a container with less than 0.5% oxygen, was used as a reference material.
  • All acetabular cups were fabricated according to prints for the Trident™ design 32 mm insert (Howmedica Osteonics Corp. Cat. No. 620-0-32E). The standard cobalt chrome femoral heads (6260-5-132) were obtained, these femoral heads were of matching diameter to the insert inside diameter of 32 mm. [0109]
  • An MTS 8-station hip simulator was used to perform the wear test. The cups were inserted into metal shells as in vivo. The shells were then secured into polyethylene holders that were in turn fitted onto stainless steel spigots. Each head was mounted onto a stainless steel taper that was part of a reservoir containing a fluid serum media. The serum reservoir was mounted on a 23-degree inclined block. A standard physiological cyclic load between two peak loads of 0.64 and 2.5 kN at 1 Hz was applied to all cups. This cyclic load was applied through the central axes of the cup, head and block. [0110]
  • The serum used for this test was a fetal-substitute alpha calf fraction serum (ACFS) diluted to a physiologically relevant value of about 20 grams per liter of total protein. A preservative (EDTA) about 0.1 vol. % was added to minimize bacteria degradation. Each reservoir contained about 450 milliliters of abovementioned ACFS with EDTA. This fluid in the reservoir was replaced with fresh ACSS with EDTA every 250,000 cycles. During the fluid replacement process, the samples were removed from the machine, cleaned and weighed. [0111]
  • Results and Discussion—The wear rate of each treatment is illustrated in Table 4; the measurement unit given is cubic millimeters per million cycles (mm[0112] 3/mc). The wear rate was corrected for the effect of fluid absorption. The cups subject to the 2X and 3X sequential cross-link processes significantly reduced wear rate in UHMWPE acetabular cups by 86 to 96% when comparing to cups that received a 3.0 MRads gamma-radiation in a container with less than 0.5% oxygen.
    TABLE 4
    Wear Rate Reduction in Wear
    Treatment (mm3/mc) Rate (%)
    GUR 1050 received 3.0 MRads 37.6 NA
    in a container with less
    than 0.5% oxygen (a
    reference material)
    GUR 1050 received 2X 5.3 86
    sequentially cross-link and
    annealed, 6.0 MRads total
    GUR 1050 received 3X 1.4 96
    sequentially cross-link and
    annealed, 9.0 MRads total
    GUR 1020 received 3X 2.5 93
    sequentially cross-link and
    annealed, 9.0 MRads
  • EXAMPLE VII Effect of Sequential Cross-link Dose on the Free Radical Concentration in UHMWPE
  • Materials and Methods—The materials for free radical concentration evaluated were: [0113]
  • 1. GUR 1050 that received 3.0 MRads in a container with less than 0.5% oxygen (A reference material). [0114]
  • 2. GUR 1050 that received 2X (6.0 MRads) sequentially cross-link and annealed. [0115]
  • 3. GUR 1050 that received 3X (9.0 MRads) sequentially cross-link and annealed. [0116]
  • 4. GUR 1050 that received a 9.0 MRads single total dose of cross-link radiation and annealed at 130° C. for 8 hours. [0117]
  • The specimens are 3 mm diameter, 10 mm long cylinders fabricated from abovementioned components. This evaluation was carried out at the University of Memphis (Physics Department, Memphis, Tenn.). Free radical concentration was measured and calculated from an average of three (3) specimens. Free radical measurements were performed using electron spin resonance technique. This is the only technique that can directly detect free radicals in solid and aqueous media. A top-of-the-line ESR spectrometer (Bruker EMX) was used in this evaluation. [0118]
  • Results and Discussion—The free radical concentration in the materials is illustrated in Table 5; the measurement unit given is spins per grams (spins/g). The materials subjected to the 2X and 3X sequential cross-link processes showed a significant reduction in free radical concentration about 94 to 98% when comparing to a GUR 1050 material that received a 3.0 MRads gamma-radiation in a container with less than 0.5% oxygen. The materials subjected to the 2X and 3X sequential cross-link processes also showed a significant reduction in free radical concentration about 82 to 92% when comparing to a GUR 1050 material that received a 9.0 MRads total dose of gamma-radiation and annealed at 130° C. for 8 hours. [0119]
    TABLE 5
    Free Radical
    Concentration Reduction in Free
    (10E + 14 Radical
    Treatment spins/g) Concentration (%)
    GUR 1050 received 3.0 MRads 204 ± 14 NA
    in a container with less than
    0.5% oxygen (a reference
    material)
    GUR 1050 received 2X  5 ± 1 98
    sequentially cross-link and
    annealed, 6.0 MRads
    GUR 1050 received 3x 12 ± 1 94
    sequentially cross-link and
    annealed, 9.0 MRads
    GUR 1050 received 9.0 MRads 67 ± 4 67
    cross-link and annealed 130° C.
    for 8 hours
  • EXAMPLE VIII Effect of Sequential Cross-link Dose on the Oxidation Resistance Property of UHMWPE
  • Materials and Methods—The materials for oxidation resistance evaluation were: [0120]
  • 1. GUR 1050 that received 3.0 MRads in a container with less than 0.5% oxygen (A reference material). [0121]
  • 2. GUR 1050 that received 3X (9.0 MRads) sequentially cross-link and annealed. [0122]
  • 3. GUR 1050 that received a 9.0 MRads single total dose of cross-link radiation and annealed at 130° for 8 hours. [0123]
  • An accelerated aging protocol per ASTM F 2003 (5 atm oxygen pressure at 70° C. for 14 days) was carried out at Exponent Failure Analysis Associates (Philadelphia, Pa.). The specimens were machined 90×20×10 mm rectangular blocks. The oxidation analysis was performed on a Nicolet model 750 Magna-IR™ spectrometer per ASTM F2102-01 using an aperture 100 μm×100 μm and 256 scans. An oxidation index was defined by the ratio of the carbonyl peak area (1660 to 1790 cm[0124] −1) to the 1370 cm−1 peak area (1330 to 1390 cm−1). A through-the-thickness (10 mm) oxidation index profile was generated from an average of three (3) specimens. The 0 and 10 mm depths represented surfaces of specimens. The maximum oxidation index of each specimen was used to determine if there was a significant difference.
  • Results and Discussion—Oxidation index profiles and the maximum oxidation index are illustrated in FIG. 1 and Table 6, respectively. The GUR 1050 materials subjected to the 3X sequential cross-link process showed a significant reduction in both an oxidation index profile and maximum oxidation index. The sequential cross-link process significantly reduced the maximum oxidation index in 3X GUR 1050 by 86% when comparing to a GUR 1050 material that received a 3.0 MRads gamma-radiation in a container with less than 0.5% oxygen. The GUR 1050 materials subjected to the 3X sequential cross-link process also showed a significant reduction in maximum oxidation index by 72% when comparing to a GUR 1050 material that received a 9.0 MRads total dose of gamma-radiation and annealed at 130° C. for 8 hours. [0125]
    TABLE 6
    Treatment Maximum Oxidation Index
    GUR 1050 received 3.0 MRads in a 2.60 ± 0.02
    container with less than 0.5% oxygen
    (a reference material)
    GUR 1050 received 3X sequentially 0.36 ± 0.02
    cross-link and annealed, 9.0 MRads
    GUR 1050 received 9.0 MRads cross-link 1.29 ± 0.03
    and annealed 130° C. for 8 hours
  • EXAMPLE IX Effect of Sequential Cross-link Dose on the Wear Properties of Direct Compression Molded UHMWPE Tibial Inserts
  • Materials and Methods—All direct compression molded (DCM) and machined Howmedica Osteonics Corp. Scorpio® PS tibial inserts were fabricated from GUR 1020 UHMWPE. DCM Scorpio® PS direct molded tibial inserts were treated with the sequential cross-link process (radiation and annealing) two times (2X), a nominal dose of 4.5 MRads during each step of radiation. The total accumulation of gamma-radiation in these components was 9.0 MRads. These components were packaged in an air impermeable pouch with less than 0.5% oxygen. Scorpio® PS tibial inserts (Howmedica Osteonics Corp. Cat. No. 72-3-0708) were machined from compression molded GUR 1020 material and obtained from an in-house order. These components then received gamma-radiation sterilization at a nominal dose of 3.0 MRads in a container with less than 0.5% oxygen. Wear test was performed on an MTS knee simulator according to an ISO standard 14243 [0126] Part 3.
  • Results and Discussion—The wear test results are illustrated in Table 7; the measurement unit given is cubic millimeters per million cycles (mm[0127] 3/mc) . The wear rate was corrected for the effect of fluid absorption. The DCM Scorpio® PS tibial inserts subjected to the 2X (4.5 MRad) sequential cross-link process significantly reduced wear rate in UHMWPE tibial inserts by 88% when comparing to Scorpio® PS tibial inserts that received a 3.0 MRads gamma-radiation in a container with less than 0.5% oxygen.
    TABLE 7
    Wear Rate Reduction in Wear
    Treatment (mm3/mc) Rate (%)
    Scorpio ® PS machined from 32.6 ± 6.8  NA
    compression molded GUR 1020,
    received 3.0 MRads in a
    container with less than
    0.5% oxygen (a reference
    material)
    DCM Scorpio ® PS GUR 1020 3.8 ± 0.1 88
    received 2X (4.5 MRads)
    sequentially cross-link and
    annealed, 9.0 MRads total
  • EXAMPLE X Effect of Sequential Cross-link Dose on the Free Radical Concentration in Direct Compression Molded UHMWPE Tibial Inserts
  • Materials and Methods—The materials for free radical concentration evaluation are the same as the wear test materials described in Example IX, above. The specimens are 3 mm diameter, 10 mm long cylinders fabricated from abovementioned components. This evaluation was carried out at the University of Memphis (Physics Department, Memphis, Tenn.). Free radical concentration was measured and calculated from an average of three (3) specimens. Free radical measurements were performed using electron spin resonance technique. This is the only technique that can directly detect free radials in solid and aqueous media. A top-of-the-line ESR spectrometer (Bruker EMX) was used in this evaluation. [0128]
  • Results and Discussion—The free radical concentration in the materials is illustrated in Table 8; the measurement unit given is spins per gram (spins/g). The DCM Scorpio® PS tibial inserts subjected to the 2X (4.5 MRads) sequential cross-link processes showed a significant reduction in free radical concentration of 97% when comparing to a Scorpio® PS machined from compression molded GUR 1020 that received a 3.0 MRads of gamma-radiation sterilization in a container with less than 0.5% oxygen. [0129]
    TABLE 8
    Free Radical
    Concentration Reduction in Free
    (10E + 14 Radical
    Treatment spins/g) Concentration (%)
    Scorpio ® PS machined from 325 ± 28 NA
    compression molded GUR
    1020, received 3.0 MRads in
    a container with less than
    0.5% oxygen (a reference
    material)
    DCM Scorpio ® PS GUR 1020  9 ± 0 97
    received 2X (4.5 MRads)
    sequentially cross-link and
    annealed, 9.0 MRads total
  • EXAMPLE XI Effect of Sequential Cross-link Dose on the Oxidation Resistance of Direct Compression Molded UHMWPE Tibial Inserts
  • Materials and Methods—The materials for oxidation resistance evaluation are the same as the wear test materials described in Example IX, above. An accelerated aging protocol per ASTM F 2003 (5 atm oxygen pressure at 70° C. for 14 days) was carried out at Howmedica Osteonics (Mahwah, N.J.). The specimens were machined and sequentially cross-link 2X (4.5 MRads) DCM Scorpio® PS tibial inserts. The oxidation analysis was performed on a Nicolet model 750 Magna-IR™ spectrometer per ASTM F2102-01 using an aperture 100 μm×100 μm and 256 scans. An oxidation index was defined by the ratio of the carbonyl peak area (1660 to 1790 cm[0130] −1) to the 1370 cm−1 peak area (1330 to 1390 cm−1). A through-the-thickness (about 6 mm) oxidation index profile was generated from an average of three (3) specimens. The 0 and 6 mm depths represented articulating and back surfaces of specimens. The maximum oxidation index of each specimen was used to determine if there was a significant difference.
  • Results and Discussion—Oxidation index profiles and the maximum oxidation index are illustrated in FIG. 2 and Table 9, respectively. The DCM Scorpio® PS tibial inserts subjected to the 2X (4.5 MRads) sequential cross-link processes showed a significant reduction in an oxidation index profile and maximum oxidation index. The sequential cross-link process reduced the maximum oxidation index in 2X (4.5 MRads) DCM GUR 1020 Scorpio® PS tibial inserts by 90% when comparing to a Scorpio® PS machined from compression molded GUR 1020 that received a 3.0 MRads of gamma-radiation sterilization in a container with less than 0.5% oxygen. [0131]
    TABLE 9
    Treatment Maximum Oxidation Index
    Scorpio ® PS machined from compression 0.30 ± 0.02
    molded GUR 1020, received 3.0 MRads in
    a container with less than 0.5% oxygen
    (a reference material)
    GUR 1020 received 2X (4.5 MRads) 3.10 ± 0.03
    sequentially cross-link and annealed,
    9.0 MRads total
  • Although the invention herein has been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the spirit and scope of the present invention as defined by the appended claims. [0132]

Claims (26)

1. A preformed material for subsequent production of a medical implant with improved wear resistance comprising a polyethylene cross-linked at least twice by irradiation and thermally treated by annealing after each irradiation.
2. The preformed material as set forth in claim 1, wherein the material is cross-linked by a total radiation dose from about 2 to about 100 MRad.
3. The preformed material as set forth in claim 2, wherein the total radiation dose is between about 5 to about 10 MRad.
4. The preformed material as set forth in claim 3, wherein three radiation doses are applied with an incremental dose for each irradiation is between about 2 and about 5 MRad.
5. The preformed material as set forth in claim 1, wherein three radiation doses are applied with an incremental dose for each irradiation being between about 2 and about 5 MRad.
6. The preformed material as set forth in claim 5, wherein the total radiation dose is between about 5 to about 10 MRad.
7. The orthopedic preformed material as set forth in claim 1, wherein the polyethylene has a weight average molecular weight of greater than 400,000.
8. The preformed material as set forth in claim 1, wherein the annealing takes place in air at a temperature greater than 25° C.
9. The preformed material as set forth in claim 8, wherein the annealing takes place for a time and temperature selected to be at least equivalent to heating said irradiated material at 50° C. for 144 hours as defined by Arrhennius equation (14).
10. The preformed material as set forth in claim 9, wherein said material is heated for at least about four hours.
11. The orthopedic preformed material as set forth in claim 1, wherein the polyethylene is at room temperature for each irradiation.
12. The preformed material as set forth in claim 1, wherein the polyethylene is cross-linked three times by irradiation and thermally treated by annealing after each irradiation at a temperature between 25° C. and 135° C. for at least 4 hours.
13. A method for increasing the wear resistance of a preformed polyethylene comprising:
irradiating the preformed polyethylene in the solid state at least two times; and
annealing the preformed polyethylene after each irradiation.
14. The method for increasing the wear resistance as set forth in claim 13, wherein the material is cross-linked by a total radiation dose from about 1 to about 100 MRad.
15. The method for increasing the wear resistance as set forth in claim 14, wherein the total radiation dose is between about 5 to about 10 MRad.
16. The method for increasing the wear resistance as set forth in claim 15, wherein an incremental dose for each irradiation is between about 2 and about 5 MRad.
17. The method for increasing the wear resistance as set forth in claim 16, wherein an incremental dose for each irradiation is between about 2 and about 5 MRad.
18. The method for increasing the wear resistance as set forth in claim 17, wherein the total radiation dose is between about 4 to about 10.5 MRad.
19. The method for increasing the wear resistance as set forth in claim 18, wherein the weight average molecular weight of the polyethylene is greater than 400,000.
20. The method for increasing the wear resistance as set forth in claim 19, wherein the annealing takes place at a temperature greater than 25° C.
21. The method as set forth in claim 29 wherein the annealing takes place between 110° C. and 135° C.
22. The method for increasing the wear resistance as set forth in claim 20, wherein the annealing takes place for a time and temperature selected to be at least equivalent to heating said irradiated material at 50° C. for 144 hours as defined by Arrhennius equation (14).
23. The method for increasing the wear resistance as set forth in claim 23, wherein said material is heated for at least about 4 hours.
24. The method as set forth in claim 13 further including the step of machining the preformed polyethylene into a medical implant.
25. The method as set forth in claim 13, wherein the material polyethylene is cross-linked three times by irradiation and thermally treated by annealing after each irradiation at a temperature between 25° C. and 135° C. for at least about 4 hours.
26. A medical device comprising a polyethylene material irradiated at least two times and annealed at a temperature lower than the melting point of the material after each irradiation.
US10/454,815 2002-06-06 2003-06-04 Sequentially cross-linked polyethylene Abandoned US20030229155A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US10/454,815 US20030229155A1 (en) 2002-06-06 2003-06-04 Sequentially cross-linked polyethylene
US10/957,782 US7517919B2 (en) 2002-06-06 2004-10-04 Sequentially cross-linked polyethylene
US12/315,994 US7714036B2 (en) 2002-06-06 2008-12-09 Sequentially cross-linked polyethylene
US12/757,394 US8030370B2 (en) 2002-06-06 2010-04-09 Sequentially cross-linked polyethylene
US13/223,422 US8324291B2 (en) 2002-06-06 2011-09-01 Sequentially cross-linked polyethylene
US13/658,037 US8680173B2 (en) 2002-06-06 2012-10-23 Sequentially cross-linked polyethylene
US14/174,035 US9181409B2 (en) 2002-06-06 2014-02-06 Sequentially cross-linked polyethylene
US14/876,344 US9650476B2 (en) 2002-06-06 2015-10-06 Sequentially cross-linked polyethylene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38666002P 2002-06-06 2002-06-06
US10/454,815 US20030229155A1 (en) 2002-06-06 2003-06-04 Sequentially cross-linked polyethylene

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/957,782 Continuation US7517919B2 (en) 2002-06-06 2004-10-04 Sequentially cross-linked polyethylene

Publications (1)

Publication Number Publication Date
US20030229155A1 true US20030229155A1 (en) 2003-12-11

Family

ID=29550211

Family Applications (8)

Application Number Title Priority Date Filing Date
US10/454,815 Abandoned US20030229155A1 (en) 2002-06-06 2003-06-04 Sequentially cross-linked polyethylene
US10/957,782 Expired - Lifetime US7517919B2 (en) 2002-06-06 2004-10-04 Sequentially cross-linked polyethylene
US12/315,994 Expired - Lifetime US7714036B2 (en) 2002-06-06 2008-12-09 Sequentially cross-linked polyethylene
US12/757,394 Expired - Lifetime US8030370B2 (en) 2002-06-06 2010-04-09 Sequentially cross-linked polyethylene
US13/223,422 Expired - Lifetime US8324291B2 (en) 2002-06-06 2011-09-01 Sequentially cross-linked polyethylene
US13/658,037 Expired - Lifetime US8680173B2 (en) 2002-06-06 2012-10-23 Sequentially cross-linked polyethylene
US14/174,035 Expired - Lifetime US9181409B2 (en) 2002-06-06 2014-02-06 Sequentially cross-linked polyethylene
US14/876,344 Expired - Lifetime US9650476B2 (en) 2002-06-06 2015-10-06 Sequentially cross-linked polyethylene

Family Applications After (7)

Application Number Title Priority Date Filing Date
US10/957,782 Expired - Lifetime US7517919B2 (en) 2002-06-06 2004-10-04 Sequentially cross-linked polyethylene
US12/315,994 Expired - Lifetime US7714036B2 (en) 2002-06-06 2008-12-09 Sequentially cross-linked polyethylene
US12/757,394 Expired - Lifetime US8030370B2 (en) 2002-06-06 2010-04-09 Sequentially cross-linked polyethylene
US13/223,422 Expired - Lifetime US8324291B2 (en) 2002-06-06 2011-09-01 Sequentially cross-linked polyethylene
US13/658,037 Expired - Lifetime US8680173B2 (en) 2002-06-06 2012-10-23 Sequentially cross-linked polyethylene
US14/174,035 Expired - Lifetime US9181409B2 (en) 2002-06-06 2014-02-06 Sequentially cross-linked polyethylene
US14/876,344 Expired - Lifetime US9650476B2 (en) 2002-06-06 2015-10-06 Sequentially cross-linked polyethylene

Country Status (7)

Country Link
US (8) US20030229155A1 (en)
EP (1) EP1369135B1 (en)
JP (1) JP4184872B2 (en)
AT (1) ATE291447T1 (en)
AU (1) AU2003204537B2 (en)
CA (1) CA2429930C (en)
DE (1) DE60300403T2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060038170A1 (en) * 2004-08-17 2006-02-23 International Business Machines Corporation Electronic device having an electrode with enhanced injection properties
US7344672B2 (en) 2004-10-07 2008-03-18 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US20080197541A1 (en) * 2005-06-14 2008-08-21 Omni Life Science, Inc Crosslinked Polyethylene Article
US7462318B2 (en) 2004-10-07 2008-12-09 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US7858671B2 (en) 1996-02-13 2010-12-28 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US8262976B2 (en) 2004-10-07 2012-09-11 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US8563623B2 (en) 1996-02-13 2013-10-22 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US20130298427A1 (en) * 2012-05-09 2013-11-14 Ticona Llc Polymer Composition and Articles For Use in Low Temperature Environments That Are Wear Resistant
US8641959B2 (en) 2007-07-27 2014-02-04 Biomet Manufacturing, Llc Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US20150166257A1 (en) * 2013-12-16 2015-06-18 2266170 Ontario Inc. Capsule with Sensory Attributes
US20150266210A1 (en) * 2014-03-21 2015-09-24 Howmedica Osteonics Corp. Annealing method for cross-linked polyethylene
CN105172154A (en) * 2015-10-23 2015-12-23 北京隆源自动成型系统有限公司 Selected region laser sintering and molding method of ultrahigh molecular weight polyethylene
US9586370B2 (en) 2013-08-15 2017-03-07 Biomet Manufacturing, Llc Method for making ultra high molecular weight polyethylene
WO2023078165A1 (en) * 2021-11-02 2023-05-11 苏州微创关节医疗科技有限公司 Ultrahigh molecular weight polyethylene implant and preparation method therefor, and artificial joint

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2429930C (en) 2002-06-06 2008-10-14 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US6932930B2 (en) * 2003-03-10 2005-08-23 Synecor, Llc Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same
JP2005237629A (en) * 2004-02-26 2005-09-08 Kyocera Corp Artificial joint and manufacturing method of the same
US7435372B2 (en) * 2005-03-31 2008-10-14 Zimmer, Inc. Liquid bath annealing of polymers for orthopaedic implants
US7538379B1 (en) * 2005-06-15 2009-05-26 Actel Corporation Non-volatile two-transistor programmable logic cell and array layout
US8461225B2 (en) 2005-08-22 2013-06-11 The General Hospital Corporation Oxidation resistant homogenized polymeric material
CA2669386A1 (en) * 2006-10-30 2008-05-08 Smith & Nephew Orthopaedics Ag Processes comprising crosslinking polyethylene or using crosslinked polyethylene
WO2008101116A1 (en) * 2007-02-14 2008-08-21 Brigham And Women's Hospital, Inc. Crosslinked polymers and methods of making the same
US20100292374A1 (en) * 2007-10-05 2010-11-18 Anuj Bellare Crosslinked polymers and methods of making the same
US8133436B2 (en) 2008-08-05 2012-03-13 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
FR2936702B1 (en) * 2008-10-02 2010-12-24 Fournitures Hospitalieres Ind METHOD FOR MANUFACTURING IMPLANTS FOR HIP PROSTHESIS, AND COTYLOID IMPLANT OBTAINED THEREBY
CA2706233C (en) * 2009-06-04 2015-05-05 Howmedica Osteonics Corp. Orthopedic peek-on-polymer bearings
GB0922339D0 (en) 2009-12-21 2010-02-03 Mcminn Derek J W Acetabular cup prothesis and introducer thereof
US9132209B2 (en) 2010-05-07 2015-09-15 Howmedia Osteonics Corp. Surface crosslinked polyethylene
GB201219686D0 (en) 2012-11-01 2012-12-12 Invibio Ltd Orthopaedic polymer-on-polymer bearings
WO2014075727A1 (en) * 2012-11-15 2014-05-22 Abb Research Ltd Cross-linked polyethylene used for electrical insulation applications
EP3068441A1 (en) * 2013-11-15 2016-09-21 SABIC Global Technologies B.V. Methods of identifying crosslinking molecules for polymers
CN107303218A (en) * 2017-04-28 2017-10-31 上海旷视医疗科技有限公司 The security control of angle/sclera crosslinking technological and efficiency optimization system

Citations (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2904480A (en) * 1955-06-06 1959-09-15 Grace W R & Co Polyethylene
US3022543A (en) * 1958-02-07 1962-02-27 Grace W R & Co Method of producing film having improved shrink energy
US3057791A (en) * 1959-07-06 1962-10-09 Phillips Petroleum Co Radiation curing of polymers
US3090770A (en) * 1960-04-26 1963-05-21 Grace W R & Co Blended polyethylene compositions of improved clarity and method of making same
US3162623A (en) * 1961-12-26 1964-12-22 Du Pont Crosslinking of polymers with nitrogen fluorides
US3297641A (en) * 1964-01-17 1967-01-10 Grace W R & Co Process for cross-linking polyethylene
US3330748A (en) * 1955-01-11 1967-07-11 Gen Electric Method and apparatus for irradiating organic polymers with electrons
US3352818A (en) * 1964-01-31 1967-11-14 Glanzstoff Ag Stability of polyolefines
US3563869A (en) * 1957-11-05 1971-02-16 Grace W R & Co Irradiated polyethylene
US3616365A (en) * 1966-05-27 1971-10-26 Basf Ag Process of making particulate expanded olefin polymers having high thermal stability
US3758273A (en) * 1970-04-03 1973-09-11 Gillette Co Processes for sterilizing polypropylene objects
US3832827A (en) * 1967-12-18 1974-09-03 J Lemelson Container forming and filling apparatus
US3886056A (en) * 1971-11-01 1975-05-27 Ryozo Kitamaru Process for producing a high melting temperature polyethylene employing irradiation and orienting
US4226905A (en) * 1978-04-18 1980-10-07 Du Pont Canada Inc. Manufacture of film from partially crosslinked polyethylene
US4587163A (en) * 1984-03-06 1986-05-06 Zachariades Anagnostis E Preparation of ultra high molecular weight polyethylene morphologies of totally fused particles with superior mechanical performance
US4655769A (en) * 1984-10-24 1987-04-07 Zachariades Anagnostis E Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states
US4701288A (en) * 1985-06-05 1987-10-20 Bausch & Lomb Incorporated Method of making articles of dissimilar polymer compositions
US4813210A (en) * 1985-09-27 1989-03-21 Nissho Corporation Radiation-sterilized, packaged medical device
US4820466A (en) * 1985-01-31 1989-04-11 Zachariades Anagnostis E Process for obtaining ultra-high modulus products
US4832965A (en) * 1985-05-17 1989-05-23 Helin Stig Aake Method of making a bottle and packaging a water ration therein
US4950151A (en) * 1985-01-31 1990-08-21 Zachariades Anagnostic E Rolling die for producing high modulus products
US5030402A (en) * 1989-03-17 1991-07-09 Zachariades Anagnostis E Process for producing a new class of ultra-high-molecular-weight polyethylene orthopaedic prostheses with enhanced mechanical properties
US5037928A (en) * 1989-10-24 1991-08-06 E. I. Du Pont De Nemours And Company Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
US5096654A (en) * 1987-07-24 1992-03-17 The National Research And Development Corporation Solid phase deformation process
US5153039A (en) * 1990-03-20 1992-10-06 Paxon Polymer Company, L.P. High density polyethylene article with oxygen barrier properties
US5160464A (en) * 1983-12-09 1992-11-03 National Research Development Corporation Polymer irradiation
US5160677A (en) * 1989-12-15 1992-11-03 United States Surgical Corporation Pressurized powder support for treating processes
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
US5428079A (en) * 1990-08-01 1995-06-27 Dsm N.V. Solution of ultra-high molecular weight polyethylene
US5508319A (en) * 1991-06-21 1996-04-16 Montell North America Inc. High melt strength, ethylene polymer, process for making it, and use thereof
US5577368A (en) * 1995-04-03 1996-11-26 Johnson & Johnson Professional, Inc. Method for improving wear resistance of polymeric bioimplantable components
US5728510A (en) * 1991-01-30 1998-03-17 Interpore International Prosthetic articles and methods for producing same
US5814423A (en) * 1996-04-25 1998-09-29 Fujitsu Limited Transmission mask for charged particle beam exposure apparatuses, and an exposure apparatus using such a transmission mask
US5834113A (en) * 1993-08-20 1998-11-10 Poly-Med, Inc Self-reinforced ultra-high molecular weight polyethylene composite medical implants
US5879400A (en) * 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US6017975A (en) * 1996-10-02 2000-01-25 Saum; Kenneth Ashley Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6143232A (en) * 1999-07-29 2000-11-07 Bristol-Meyers Squibb Company Method of manufacturing an articulating bearing surface for an orthopaedic implant
US6165220A (en) * 1996-10-15 2000-12-26 The Orthopaedic Hospital Wear resistant surface-gradient crosslinked polyethylene
US6168626B1 (en) * 1994-09-21 2001-01-02 Bmg Incorporated Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
US6184265B1 (en) * 1999-07-29 2001-02-06 Depuy Orthopaedics, Inc. Low temperature pressure stabilization of implant component
US6228900B1 (en) * 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6281264B1 (en) * 1995-01-20 2001-08-28 The Orthopaedic Hospital Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US6432349B1 (en) * 1999-06-29 2002-08-13 Zimmer, Inc. Process of making an articulating bearing surface
US6503439B1 (en) * 2000-06-15 2003-01-07 Albert H. Burstein Process for forming shaped articles of ultra high molecular weight polyethylene suitable for use as a prosthetic device or a component thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US543471A (en) * 1895-07-30 Wire winding and distributing machine
US3362897A (en) 1962-11-21 1968-01-09 Gen Electric Stable irradiated polyethylene
US4241463A (en) 1978-10-16 1980-12-30 Precision Cast Specialties, Inc. Prosthetic implant device
WO1980002671A1 (en) 1979-06-06 1980-12-11 Nat Res Dev Polymer processing
US5017627A (en) 1980-10-09 1991-05-21 National Research Development Corporation Composite material for use in orthopaedics
US4586995A (en) 1982-09-17 1986-05-06 Phillips Petroleum Company Polymer and irradiation treatment method
JPS5971830A (en) 1982-10-18 1984-04-23 Nippon Sheet Glass Co Ltd Manufacture of lens of refractive index distribution type
EP0157601B1 (en) 1984-03-30 1991-05-08 National Research Development Corporation Tubular materials
EP0161802B1 (en) 1984-04-13 1990-06-27 National Research Development Corporation Solid phase deformation process
IN166935B (en) 1985-01-31 1990-08-11 Himont Inc
US5047446A (en) 1988-07-22 1991-09-10 Himont Incorporated Thermal treatment of irradiated propylene polymer material
ZA896852B (en) 1988-08-03 1991-04-24 Iso Ster Proprietary Limited Cross-linking of polymeric materials
GB8827967D0 (en) 1988-11-30 1989-01-05 Ward I M Die-free drawing
ATE138810T1 (en) 1988-12-02 1996-06-15 Du Pont LINEAR POLYETHYLENE OF ULTRA HIGH MOLECULAR WEIGHT, ARTICLES AND METHOD FOR THE PRODUCTION THEREOF
EP0449878B1 (en) 1988-12-02 1995-05-24 E.I. Du Pont De Nemours And Company Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
JPH02207436A (en) 1989-02-07 1990-08-17 Fuji Electric Co Ltd Trip cross bar of circuit breaker
CA2031406C (en) 1989-12-21 2002-05-28 Paolo Galli Graft copolymers of polyolefins and a method of producing same
US5200439A (en) 1990-04-13 1993-04-06 Mitsui Toatsu Chemicals, Inc. Method for increasing intrinsic viscosity of syndiotactic polypropylene
US5352732A (en) 1990-08-07 1994-10-04 E. I. Du Pont De Nemours And Company Homogeneous, high modulus ultrahigh molecular weight polyethylene composites and processes for the preparation thereof
US5292584A (en) 1991-04-11 1994-03-08 E. I. Du Pont De Nemours And Company Ultrahigh molecular weight polyethylene and lightly-filled composites thereof
US5466530A (en) 1993-01-21 1995-11-14 England; Garry L. Biocompatible components fabricated from a substantially consolidated stock of material
US5609643A (en) 1995-03-13 1997-03-11 Johnson & Johnson Professional, Inc. Knee joint prosthesis
JP2984203B2 (en) 1995-10-31 1999-11-29 京セラ株式会社 Manufacturing method of sliding member for artificial joint
PL189272B1 (en) * 1996-02-13 2005-07-29 Gen Hospital Corp Prosthetic device made of irradiated and fused polyethylene of ultrahigh molecular weight
US8563623B2 (en) * 1996-02-13 2013-10-22 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US5753182A (en) 1996-02-14 1998-05-19 Biomet, Inc. Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components
EP1795212A3 (en) * 1996-07-09 2007-09-05 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US5874123A (en) 1997-01-24 1999-02-23 Park; Joon B. Precoated polymeric prosthesis and process for making same
WO2000062717A1 (en) 1999-04-21 2000-10-26 Howmedica Osteonics Corp. Selectively cross-linked polyethylene orthopedic devices
JP3598920B2 (en) 1999-12-10 2004-12-08 株式会社Nhvコーポレーション Electron beam irradiation method
WO2001052110A2 (en) 2000-01-13 2001-07-19 Orbidex, Inc. System and method of searching and gathering information on-line and off-line
US6547828B2 (en) 2001-02-23 2003-04-15 Smith & Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for medical implant use
WO2003059200A1 (en) 2002-01-04 2003-07-24 Massachusetts General Hospital A high modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
CA2429930C (en) * 2002-06-06 2008-10-14 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US7384430B2 (en) * 2004-06-30 2008-06-10 Depuy Products, Inc. Low crystalline polymeric material for orthopaedic implants and an associated method
US7462318B2 (en) * 2004-10-07 2008-12-09 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US7836897B2 (en) 2007-10-05 2010-11-23 R.J. Reynolds Tobacco Company Cigarette having configured lighting end

Patent Citations (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330748A (en) * 1955-01-11 1967-07-11 Gen Electric Method and apparatus for irradiating organic polymers with electrons
US2904480A (en) * 1955-06-06 1959-09-15 Grace W R & Co Polyethylene
US3563869A (en) * 1957-11-05 1971-02-16 Grace W R & Co Irradiated polyethylene
US3022543A (en) * 1958-02-07 1962-02-27 Grace W R & Co Method of producing film having improved shrink energy
US3057791A (en) * 1959-07-06 1962-10-09 Phillips Petroleum Co Radiation curing of polymers
US3090770A (en) * 1960-04-26 1963-05-21 Grace W R & Co Blended polyethylene compositions of improved clarity and method of making same
US3162623A (en) * 1961-12-26 1964-12-22 Du Pont Crosslinking of polymers with nitrogen fluorides
US3297641A (en) * 1964-01-17 1967-01-10 Grace W R & Co Process for cross-linking polyethylene
US3352818A (en) * 1964-01-31 1967-11-14 Glanzstoff Ag Stability of polyolefines
US3616365A (en) * 1966-05-27 1971-10-26 Basf Ag Process of making particulate expanded olefin polymers having high thermal stability
US3832827A (en) * 1967-12-18 1974-09-03 J Lemelson Container forming and filling apparatus
US3758273A (en) * 1970-04-03 1973-09-11 Gillette Co Processes for sterilizing polypropylene objects
US3886056A (en) * 1971-11-01 1975-05-27 Ryozo Kitamaru Process for producing a high melting temperature polyethylene employing irradiation and orienting
US4226905A (en) * 1978-04-18 1980-10-07 Du Pont Canada Inc. Manufacture of film from partially crosslinked polyethylene
US5160464A (en) * 1983-12-09 1992-11-03 National Research Development Corporation Polymer irradiation
US4587163A (en) * 1984-03-06 1986-05-06 Zachariades Anagnostis E Preparation of ultra high molecular weight polyethylene morphologies of totally fused particles with superior mechanical performance
US4587163B1 (en) * 1984-03-06 1990-04-03 E Zachariades Anagnostis
US4655769A (en) * 1984-10-24 1987-04-07 Zachariades Anagnostis E Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states
US4820466A (en) * 1985-01-31 1989-04-11 Zachariades Anagnostis E Process for obtaining ultra-high modulus products
US4950151A (en) * 1985-01-31 1990-08-21 Zachariades Anagnostic E Rolling die for producing high modulus products
US4832965A (en) * 1985-05-17 1989-05-23 Helin Stig Aake Method of making a bottle and packaging a water ration therein
US4701288A (en) * 1985-06-05 1987-10-20 Bausch & Lomb Incorporated Method of making articles of dissimilar polymer compositions
US4813210A (en) * 1985-09-27 1989-03-21 Nissho Corporation Radiation-sterilized, packaged medical device
US5096654A (en) * 1987-07-24 1992-03-17 The National Research And Development Corporation Solid phase deformation process
US5030402A (en) * 1989-03-17 1991-07-09 Zachariades Anagnostis E Process for producing a new class of ultra-high-molecular-weight polyethylene orthopaedic prostheses with enhanced mechanical properties
US5037928A (en) * 1989-10-24 1991-08-06 E. I. Du Pont De Nemours And Company Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
US5160677A (en) * 1989-12-15 1992-11-03 United States Surgical Corporation Pressurized powder support for treating processes
US5153039A (en) * 1990-03-20 1992-10-06 Paxon Polymer Company, L.P. High density polyethylene article with oxygen barrier properties
US5428079A (en) * 1990-08-01 1995-06-27 Dsm N.V. Solution of ultra-high molecular weight polyethylene
US5728510A (en) * 1991-01-30 1998-03-17 Interpore International Prosthetic articles and methods for producing same
US5508319A (en) * 1991-06-21 1996-04-16 Montell North America Inc. High melt strength, ethylene polymer, process for making it, and use thereof
US5449745A (en) * 1993-06-01 1995-09-12 Howmedica Inc. Non-oxidizing polymeric medical implant
US5650485A (en) * 1993-06-01 1997-07-22 Howmedica Inc. Non-oxidizing polymeric medical implant
US5728748A (en) * 1993-06-01 1998-03-17 Howmedica Inc. Non oxidizing polymeric medical implant
US6372814B1 (en) * 1993-06-01 2002-04-16 Stryker Technologies Corporation Non-oxidizing polymeric medical implant
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
US6174934B1 (en) * 1993-06-01 2001-01-16 Stryker Technologies Corporation Non-oxidizing polymeric medical implant
US5834113A (en) * 1993-08-20 1998-11-10 Poly-Med, Inc Self-reinforced ultra-high molecular weight polyethylene composite medical implants
US6168626B1 (en) * 1994-09-21 2001-01-02 Bmg Incorporated Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
US6281264B1 (en) * 1995-01-20 2001-08-28 The Orthopaedic Hospital Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US5577368A (en) * 1995-04-03 1996-11-26 Johnson & Johnson Professional, Inc. Method for improving wear resistance of polymeric bioimplantable components
US5879400A (en) * 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US5814423A (en) * 1996-04-25 1998-09-29 Fujitsu Limited Transmission mask for charged particle beam exposure apparatuses, and an exposure apparatus using such a transmission mask
US6228900B1 (en) * 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6017975A (en) * 1996-10-02 2000-01-25 Saum; Kenneth Ashley Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6165220A (en) * 1996-10-15 2000-12-26 The Orthopaedic Hospital Wear resistant surface-gradient crosslinked polyethylene
US6432349B1 (en) * 1999-06-29 2002-08-13 Zimmer, Inc. Process of making an articulating bearing surface
US6143232A (en) * 1999-07-29 2000-11-07 Bristol-Meyers Squibb Company Method of manufacturing an articulating bearing surface for an orthopaedic implant
US6184265B1 (en) * 1999-07-29 2001-02-06 Depuy Orthopaedics, Inc. Low temperature pressure stabilization of implant component
US6503439B1 (en) * 2000-06-15 2003-01-07 Albert H. Burstein Process for forming shaped articles of ultra high molecular weight polyethylene suitable for use as a prosthetic device or a component thereof

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858671B2 (en) 1996-02-13 2010-12-28 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US8865788B2 (en) 1996-02-13 2014-10-21 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US8563623B2 (en) 1996-02-13 2013-10-22 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US8263676B2 (en) 1996-02-13 2012-09-11 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US8288941B2 (en) 2004-08-17 2012-10-16 International Business Machines Corporation Electronic device having an electrode with enhanced injection properties
US8021710B2 (en) 2004-08-17 2011-09-20 International Business Machines Corporation Electronic device having an electrode with enhanced injection properties
US20100308316A1 (en) * 2004-08-17 2010-12-09 International Business Machines Corporation Electronic Device Having an Electrode With Enhanced Injection Properties
US20060038170A1 (en) * 2004-08-17 2006-02-23 International Business Machines Corporation Electronic device having an electrode with enhanced injection properties
US8398913B2 (en) 2004-10-07 2013-03-19 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7927536B2 (en) 2004-10-07 2011-04-19 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US8137608B2 (en) 2004-10-07 2012-03-20 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US8262976B2 (en) 2004-10-07 2012-09-11 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7462318B2 (en) 2004-10-07 2008-12-09 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US7780896B2 (en) 2004-10-07 2010-08-24 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US7993401B2 (en) 2004-10-07 2011-08-09 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7344672B2 (en) 2004-10-07 2008-03-18 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US9017590B2 (en) 2004-10-07 2015-04-28 Biomet Manufacturing, Llc Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7803310B2 (en) 2005-06-14 2010-09-28 Omni Life Science, Inc. Crosslinked polyethylene article
US20080197541A1 (en) * 2005-06-14 2008-08-21 Omni Life Science, Inc Crosslinked Polyethylene Article
US9421104B2 (en) 2007-07-27 2016-08-23 Biomet Manufacturing, Llc Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US8641959B2 (en) 2007-07-27 2014-02-04 Biomet Manufacturing, Llc Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US20130298427A1 (en) * 2012-05-09 2013-11-14 Ticona Llc Polymer Composition and Articles For Use in Low Temperature Environments That Are Wear Resistant
US9328229B2 (en) * 2012-05-09 2016-05-03 Ticona Llc Polymer composition and articles for use in low temperature environments that are wear resistant
US9586370B2 (en) 2013-08-15 2017-03-07 Biomet Manufacturing, Llc Method for making ultra high molecular weight polyethylene
US20150166257A1 (en) * 2013-12-16 2015-06-18 2266170 Ontario Inc. Capsule with Sensory Attributes
US20150266210A1 (en) * 2014-03-21 2015-09-24 Howmedica Osteonics Corp. Annealing method for cross-linked polyethylene
CN105172154A (en) * 2015-10-23 2015-12-23 北京隆源自动成型系统有限公司 Selected region laser sintering and molding method of ultrahigh molecular weight polyethylene
WO2023078165A1 (en) * 2021-11-02 2023-05-11 苏州微创关节医疗科技有限公司 Ultrahigh molecular weight polyethylene implant and preparation method therefor, and artificial joint

Also Published As

Publication number Publication date
US20130046042A1 (en) 2013-02-21
US9181409B2 (en) 2015-11-10
US7714036B2 (en) 2010-05-11
CA2429930C (en) 2008-10-14
US20120029160A1 (en) 2012-02-02
AU2003204537A1 (en) 2004-01-08
AU2003204537B2 (en) 2008-02-28
JP2004043798A (en) 2004-02-12
JP4184872B2 (en) 2008-11-19
ATE291447T1 (en) 2005-04-15
DE60300403D1 (en) 2005-04-28
US9650476B2 (en) 2017-05-16
US20160024261A1 (en) 2016-01-28
EP1369135B1 (en) 2005-03-23
US20100197881A1 (en) 2010-08-05
US8324291B2 (en) 2012-12-04
US7517919B2 (en) 2009-04-14
US8680173B2 (en) 2014-03-25
CA2429930A1 (en) 2003-12-06
DE60300403T2 (en) 2006-03-09
US20050043431A1 (en) 2005-02-24
US20140194548A1 (en) 2014-07-10
US20090105439A1 (en) 2009-04-23
EP1369135A1 (en) 2003-12-10
US8030370B2 (en) 2011-10-04

Similar Documents

Publication Publication Date Title
US9650476B2 (en) Sequentially cross-linked polyethylene
US9155817B2 (en) Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US8003709B2 (en) Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6228900B1 (en) Crosslinking of polyethylene for low wear using radiation and thermal treatments
AU2001261083A1 (en) Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US20050125074A1 (en) Crosslinking of polyethylene for low wear using radiation and thermal treatments
EP2921186B1 (en) Annealing method for cross-linked polyethylene

Legal Events

Date Code Title Description
AS Assignment

Owner name: HOWMEDICA OSTEONICS CORP., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WANG, AIGUO;DUMBLETON, JOHN H.;REEL/FRAME:014156/0760

Effective date: 20030530

STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION